{"study_id": 74602, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness of monotherapies, including Minoxidil, for treating androgenetic alopecia in men.", "results_summary": "The study found that oral 5-alpha reductase inhibitors were more effective than oral Minoxidil and newer treatments like Botox, microneedling, and photobiomodulation. Minoxidil's effectiveness was noted to be dose-dependent but less impactful compared to other treatments.", "population_specificity": "Adult men aged 18 years and above with androgenetic alopecia.", "effective_dosage": "Not specified for Minoxidil.", "study_duration": "24 weeks (6 months).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:28.351911+00:00"}
{"study_id": 74605, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to review the safety and effectiveness of FDA-approved treatments like minoxidil and finasteride, as well as newer alternatives, for male androgenetic alopecia (AGA).", "results_summary": "The abstract indicates that topical minoxidil is an FDA-approved and preferred treatment for male AGA, though some patients may not respond satisfactorily or experience side effects. No specific efficacy data for minoxidil is provided in the abstract.", "population_specificity": "Male patients with androgenetic alopecia (AGA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:28.753076+00:00"}
{"study_id": 74601, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to compare the safety and efficacy of spironolactone versus bicalutamide, both used alongside topical minoxidil 2%, in treating female-pattern hair loss (FPHL).", "results_summary": "The study found that bicalutamide showed greater efficacy than spironolactone, with a statistically significant reduction in hair loss severity (28.20% vs. 19.51%) and marked improvement in global photographic assessment. Both groups used topical minoxidil 2%, but the abstract does not isolate minoxidil's individual effects.", "population_specificity": "Females aged 18\u201350 years diagnosed with FPHL.", "effective_dosage": "Topical minoxidil 2% (frequency not specified).", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:28.862431+00:00"}
{"study_id": 74588, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to review the treatment options for different types of alopecia, including the role of minoxidil as a first-line treatment for androgenetic alopecia.", "results_summary": "The study found that minoxidil is a first-line treatment for androgenetic alopecia, which is the most common form of hair loss. It also noted that oral finasteride is another treatment option for male patients.", "population_specificity": "Patients with androgenetic alopecia (patterned hair loss).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:29.892435+00:00"}
{"study_id": 74607, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 40, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the role of Minoxidil in treating filler-induced alopecia, particularly as an adjunct therapy.", "results_summary": "Minoxidil was found to play a minor role in restoring hair growth in filler-induced alopecia, often used alongside hyaluronidase (HAase) to facilitate recovery. Its effects were less pronounced compared to HAase, which showed rapid restoration of hair density.", "population_specificity": "Patients with filler-induced alopecia, primarily following hyaluronic acid injections.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:30.016157+00:00"}
{"study_id": 74606, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to assess the efficacy of minoxidil and other light therapies in managing androgenetic alopecia and alopecia areata.", "results_summary": "The abstract notes that minoxidil is partially efficacious for all patients, often requiring adjunct therapies like laser-based treatments for better outcomes. No specific efficacy data or statistical results are provided.", "population_specificity": "Patients with androgenetic alopecia and alopecia areata (general population, no specific demographics mentioned).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:30.554299+00:00"}
{"study_id": 74609, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to review reported treatment options, including minoxidil, for pediatric patients with alopecia areata.", "results_summary": "The study included minoxidil among commonly used therapies for pediatric alopecia areata, noting variable efficacy and the frequent need for combination therapy for optimal results. No specific outcomes or statistical data for minoxidil were detailed in the abstract.", "population_specificity": "Pediatric patients with alopecia areata", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:31.820211+00:00"}
{"study_id": 74612, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to describe the clinical and sociodemographic characteristics of alopecia areata patients in Colombia, including treatment patterns such as the use of topical minoxidil.", "results_summary": "The study found that 5% topical minoxidil was the second most widely used treatment (46.4%) for alopecia areata, following steroid injections (76.4%). No specific efficacy outcomes for minoxidil were detailed in the abstract.", "population_specificity": "Patients diagnosed with alopecia areata in five Colombian cities (Bogota, Cali, Cartagena, Barranquilla, and Medellin), predominantly women (59.4%) aged 15-49 years (63.9%).", "effective_dosage": "5% topical minoxidil (frequency not specified).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:35.386839+00:00"}
{"study_id": 74615, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the therapeutic benefits of 1565 nm non-ablative fractional laser (NAFL) versus 5% minoxidil in treating androgenetic alopecia (AGA).", "results_summary": "Both 1565 nm NAFL and 5% minoxidil significantly improved hair density and diameter at Week 10 compared to baseline. However, NAFL showed superior improvements in total hair number and density compared to minoxidil.", "population_specificity": "Thirty patients with androgenetic alopecia (AGA).", "effective_dosage": "5% minoxidil (frequency not specified).", "study_duration": "10 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:37.177325+00:00"}
{"study_id": 74617, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the role of oral minoxidil as an adjuvant therapy in alopecia areata and its potential efficacy.", "results_summary": "The abstract mentions that oral minoxidil is considered an adjuvant therapy with limited data confirming its possible efficacy, suggesting modest or uncertain effects.", "population_specificity": "Patients with alopecia areata, including severe cases (alopecia totalis, alopecia universalis).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:37.532941+00:00"}
{"study_id": 74614, "supplement_id": 1344, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the pharmacokinetics, mechanism of action, safety, and efficacy of oral minoxidil for treating androgenetic alopecia (AGA) in both males and females, comparing it to other available treatments.", "results_summary": "The study found that low-dose oral minoxidil (LDOM) demonstrated a favorable efficacy and safety profile in treating male and female AGA, with increasing off-label use, though optimal dosage and monitoring guidelines require further research. LDOM also showed some effectiveness in other forms of hair loss.", "population_specificity": "Males and females with androgenetic alopecia (AGA).", "effective_dosage": "Low-dose oral minoxidil (specific dosage not mentioned).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:37.645029+00:00"}
{"study_id": 74613, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of laser and energy-assisted drug delivery (LEADD) of minoxidil for treating alopecia areata (AA) and androgenetic alopecia (AGA)/pattern hair loss (PHL).", "results_summary": "The study found that LEADD with minoxidil showed a positive treatment effect for AGA/PHL, supported by multiple RCTs, though some trials did not find it superior to monotherapy or microneedling-assisted drug delivery. Minoxidil was effective when combined with all evaluated devices for AGA/PHL.", "population_specificity": "Patients with alopecia areata (AA) and androgenetic alopecia (AGA)/pattern hair loss (PHL).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:38.047323+00:00"}
{"study_id": 74616, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy of 5% topical minoxidil versus platelet-rich plasma (PRP) in treating androgenetic alopecia (AGA).", "results_summary": "At 6 months, 77% of minoxidil-treated patients had a negative hair pull test, and 91.4% reported scalp improvement, but PRP showed higher efficacy (74.5% vs. 43.7%) in effectiveness comparisons.", "population_specificity": "70 AGA patients aged 18-60 years of either gender.", "effective_dosage": "5% topical minoxidil (frequency not specified).", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:38.923559+00:00"}
{"study_id": 74619, "supplement_id": 1344, "safety_score": "65", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to compare the impact of minoxidil and finasteride on male reproductive health, specifically focusing on testis and epididymis in adult murine models.", "results_summary": "Minoxidil was found to act as a hormone disruptor, causing oxidative stress and morphological changes mainly in the testis, but its impact on male fertility was less severe compared to finasteride. The study concluded that minoxidil was less associated with reproductive injuries than finasteride.", "population_specificity": "Adult murine models (mice/rats)", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:39.909805+00:00"}
{"study_id": 74618, "supplement_id": 1344, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "To compare the effectiveness and safety of topical minoxidil versus 1 mg daily oral minoxidil in treating androgenetic alopecia.", "results_summary": "Both topical and oral minoxidil significantly improved hair diameter, with no significant difference between the two. Topical minoxidil showed better hair density improvement in photographic assessment, but overall, oral minoxidil was similarly effective and safe. Over 60% of patients in both groups were satisfied with their treatment.", "population_specificity": "65 patients with androgenetic alopecia (male and female pattern hair loss).", "effective_dosage": "5% topical solution or 1 mg/day oral minoxidil.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:40.696776+00:00"}
{"study_id": 74622, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 69, "quality_score": 82, "study_goal": "The researchers aimed to compare the efficacy of PRP therapy and topical minoxidil for treating androgenetic alopecia in a Pakistani population.", "results_summary": "The study found that minoxidil had a 69.4% negative hair pull rate after 12 weeks, which was significantly lower than the 91.7% rate in the PRP group, suggesting PRP was more effective.", "population_specificity": "Pakistani patients with androgenetic alopecia.", "effective_dosage": "5% topical minoxidil (frequency not specified).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:46.132326+00:00"}
{"study_id": 74623, "supplement_id": 1344, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to compare the efficacy of combination therapy (topical minoxidil and microneedling) versus topical minoxidil alone for treating androgenetic alopecia.", "results_summary": "The meta-analysis found a statistically significant increase in total hair count with combination therapy, but no significant increase in hair diameter. No serious adverse events were reported.", "population_specificity": "Patients with clinically diagnosed androgenetic alopecia (466 participants across 10 randomized controlled trials).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:46.160605+00:00"}
{"study_id": 74620, "supplement_id": 1344, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of combining 5% topical minoxidil (MNX) and 0.25% topical finasteride (F) compared to their use as monotherapies in treating androgenetic alopecia (AGA).", "results_summary": "The combination of 5% MNX and 0.25% F showed significantly higher hair density improvements compared to monotherapies, with comparable tolerability and safety. All treatments increased hair density, but the improvement was statistically significant only for the combination group.", "population_specificity": "42 males, aged 24\u00b13 years, with AGA (Norwood-Hamilton Grading Scale I-VII), treatment-naive or free from therapy for at least 6 months.", "effective_dosage": "5% MNX applied twice daily (group C) or once daily (group A), and 0.25% F spray applied once daily (groups A and B).", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:46.571520+00:00"}
{"study_id": 74621, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to compare the therapeutic effects of finasteride and hydroxychloroquine in treating frontal fibrosing alopecia (FFA), with minoxidil used as part of the topical treatment regimen in both groups.", "results_summary": "The study found that both finasteride and hydroxychloroquine groups, which included topical minoxidil, showed significant improvements in FFA severity scores and trichoscopic assessments, with no significant difference between the two groups. Over 60% of patients in both groups showed improvement based on photographic assessment.", "population_specificity": "34 female patients with frontal fibrosing alopecia (FFA).", "effective_dosage": "Not specified for minoxidil (used as part of topical treatment).", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:47.314497+00:00"}
{"study_id": 74624, "supplement_id": 1344, "safety_score": "85", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety of low-dose oral minoxidil (LDOM) in patients with hypertension or arrhythmia.", "results_summary": "The study found that LDOM had a favorable safety profile in patients with hypertension or arrhythmia, with systemic adverse effects occurring in 6.8% of cases, leading to discontinuation in 1.5%. Prior treatment with doxazosin or multiple antihypertensive drugs was associated with a higher risk of discontinuation.", "population_specificity": "Patients with hypertension or arrhythmia (254 patients, mean age 56.9 years, 69.3% women).", "effective_dosage": "Not specified (dose titration in 128 patients, analyzed across 382 doses).", "study_duration": "Not specified.", "interactions": "Prior treatment with doxazosin or multiple antihypertensive drugs increased discontinuation risk.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:47.803681+00:00"}
{"study_id": 74627, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the clinical debut and advancements of low-dose oral minoxidil for androgenetic alopecia.", "results_summary": "The abstract mentions the introduction of low-dose oral minoxidil but does not provide specific efficacy results. It highlights advancements in treatment options, including minoxidil, but lacks detailed findings.", "population_specificity": "Not specified", "effective_dosage": "Low-dose (specific amount not provided)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:47.827214+00:00"}
{"study_id": 74626, "supplement_id": 1344, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to investigate the efficacy of combining adipose tissue-derived stem cell conditioned media (ADSC-CM) with minoxidil for hair regeneration therapy in male androgenetic alopecia (AGA).", "results_summary": "The study found that hair count, density, and mean thickness significantly increased after 6 weeks of combined treatment with ADSC-CM and minoxidil, with no statistically significant differences between concentrated and non-concentrated ADSC-CM groups. Minimal side effects were reported, and subjects were satisfied with the results.", "population_specificity": "Male patients with androgenetic alopecia (AGA).", "effective_dosage": "5% minoxidil applied twice daily.", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:48.777616+00:00"}
{"study_id": 74625, "supplement_id": 1344, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effectiveness of topical minoxidil combined with oral spironolactone versus topical minoxidil combined with oral finasteride in treating androgenic alopecia (AGA) in women.", "results_summary": "Both treatment groups showed improvements in hair density, thickness, and hair loss, but the minoxidil-spironolactone combination was significantly more effective than minoxidil-finasteride after 4 months, particularly in male pattern hair loss (MPHL). Patient satisfaction was also higher with the minoxidil-spironolactone combination.", "population_specificity": "60 women with androgenic alopecia (AGA), including female and male pattern hair loss (FPHL and MPHL).", "effective_dosage": "2% minoxidil solution (topical) combined with either 100 mg/day spironolactone or 5 mg/day finasteride.", "study_duration": "4 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:49.754007+00:00"}
{"study_id": 74629, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the efficacy of mesotherapy, including minoxidil, for treating hair loss by summarizing current literature.", "results_summary": "Several studies reported statistically significant improvements in hair growth after mesotherapy with minoxidil, but standardized regimens are lacking, and adverse effects have been noted.", "population_specificity": "Individuals with hair loss disorders (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:53.126132+00:00"}
{"study_id": 74630, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to evaluate current alopecia treatments, including minoxidil, and explore new strategies to improve drug penetration and reduce side effects.", "results_summary": "The abstract mentions that commercial products like minoxidil face limitations due to the stratum corneum barrier and systemic adverse effects, but it does not provide specific efficacy data for minoxidil. New strategies, such as soluble microneedles, show promise but require further study.", "population_specificity": "Not specified (general alopecia patients, likely including men and women).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:54.867946+00:00"}
{"study_id": 74628, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the efficacy of topical 5% minoxidil alone versus its combination with fractional ablative erbium YAG laser in treating moderate to severe androgenetic alopecia in men.", "results_summary": "Both minoxidil alone and its combination with laser treatment showed statistically significant improvements in patient satisfaction, photography, and dermoscopy scores. The combination group had a higher dermoscopy score than minoxidil alone, but no difference was observed in photography scores.", "population_specificity": "30 male patients with moderate to severe androgenetic alopecia.", "effective_dosage": "1 mL of topical 5% minoxidil twice daily.", "study_duration": "Six sessions of laser treatment (duration per session not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:55.340829+00:00"}
{"study_id": 74633, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers aimed to review the role of topical minoxidil in treating pressure-induced alopecias (PAs) and differentiate its effects from other causes of hair loss.", "results_summary": "The abstract states that the role of topical minoxidil in treating PAs remains unknown, as the condition is usually self-limited and reversible without treatment.", "population_specificity": "Patients with pressure-induced alopecias (type 1 and type 2).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:55.949344+00:00"}
{"study_id": 74631, "supplement_id": 1344, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and safety of PRP prepared by an automatic blood cell separator combined with topical 5% minoxidil therapy in male androgenetic alopecia (AGA).", "results_summary": "The study found that PRP combined with 5% minoxidil (group A) showed superior clinical efficacy and higher patient satisfaction compared to PRP alone (group B), though the difference in hair density/quantity was not statistically significant. No serious adverse reactions were reported.", "population_specificity": "Thirty male patients with mild-to-moderate androgenetic alopecia.", "effective_dosage": "Topical 5% minoxidil (frequency not specified).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:56.172489+00:00"}
{"study_id": 74632, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy and safety of 0.01%, 0.03% bimatoprost, and 2% minoxidil gel formulations for enhancing eyebrow growth in individuals with hypotrichosis.", "results_summary": "The study found that all three treatments significantly improved eyebrow growth (GEBA score), with no statistically significant difference between minoxidil and bimatoprost. The 0.03% bimatoprost concentration showed a slightly more favorable response.", "population_specificity": "60 male and female subjects aged 18+ with eyebrow hypotrichosis (Grade 1 or 2 on the GEBA scale).", "effective_dosage": "2% minoxidil gel applied once daily.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:57.768176+00:00"}
{"study_id": 74635, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the efficacy of combining PRPF injections with minoxidil treatment for androgenetic alopecia (AGA) compared to monotherapy.", "results_summary": "The study found that combined PRPF and minoxidil therapy significantly improved hair count, terminal hair, and growth rate compared to monotherapy, with all groups showing improvements.", "population_specificity": "75 patients with androgenetic alopecia (AGA).", "effective_dosage": "Topical minoxidil 5% applied twice daily.", "study_duration": "6 months (PRPF injections were administered three times, 1 month apart).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:57.800024+00:00"}
{"study_id": 74634, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 89, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy of minoxidil, finasteride, and dutasteride in treating pattern hair loss (PHL) in adult women using a network meta-analysis.", "results_summary": "The study found that 5% topical minoxidil solution twice daily for 24 weeks was highly effective (SUCRA = 89.5%), ranking second only to 5 mg/day finasteride. Other minoxidil formulations and dosages also showed varying degrees of efficacy, with lower concentrations and less frequent applications being less effective.", "population_specificity": "Adult women with pattern hair loss (PHL).", "effective_dosage": "5% topical solution twice daily, 1 mg/day oral, 5% foam once daily, 3% solution twice daily, 2% solution twice daily, 5% solution once daily, 0.25 mg/day oral.", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:58.894048+00:00"}
{"study_id": 74636, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review current and emerging interventions, including minoxidil, for preventing or treating chemotherapy-induced alopecia (CIA).", "results_summary": "The abstract mentions topical and oral minoxidil as potential interventions to stimulate hair regrowth after CIA, but no specific efficacy data or outcomes are provided.", "population_specificity": "Cancer patients receiving chemotherapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:00.211540+00:00"}
{"study_id": 74637, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the role of gender in treatment decisions for androgenetic alopecia and highlight FDA-approved nonsurgical treatments, including minoxidil.", "results_summary": "The abstract mentions minoxidil as one of the FDA-approved treatments for androgenetic alopecia, suggesting its efficacy, but does not provide specific results. Platelet-rich plasma injections are noted as promising adjuncts.", "population_specificity": "Men and women with androgenetic alopecia.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:02.560283+00:00"}
{"study_id": 74638, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the mechanisms of action, costs, efficacies, and safety profiles of existing, alternative, and upcoming therapeutics for androgenetic alopecia, including Minoxidil.", "results_summary": "The abstract indicates that Minoxidil is one of only two FDA-approved drugs for androgenetic alopecia, suggesting its recognized efficacy, but does not provide specific results on its performance in this study.", "population_specificity": "Individuals with androgenetic alopecia (male and female pattern hair loss).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:03.216312+00:00"}
{"study_id": 74640, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effectiveness and limitations of topical minoxidil as a treatment for female-pattern hair loss (FPHL).", "results_summary": "Topical minoxidil is the only treatment with a high level of evidence for FPHL, but about 40% of patients do not show improvement. The study highlights the lack of robust randomized controlled trials and explores alternative treatments for unresponsive cases.", "population_specificity": "Females with androgenetic alopecia or female-pattern hair loss (FPHL).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:04.419000+00:00"}
{"study_id": 74639, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to compare the effects of activated versus non-activated platelet-rich plasma (PRP) and baseline platelet count on hair density and thickness in androgenetic alopecia, not specifically to evaluate Minoxidil.", "results_summary": "The study found that activated PRP significantly improved hair density after four months and hair thickness at six months. Higher platelet counts in PRP led to greater improvements in hair density and thickness over time.", "population_specificity": "Patients with androgenetic alopecia (80 participants).", "effective_dosage": "Not mentioned (study focused on PRP injections, not Minoxidil).", "study_duration": "Monthly interventions for three months, followed by a three-month follow-up.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:04.757705+00:00"}
{"study_id": 74642, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the effectiveness of topical minoxidil in treating erectile dysfunction (ED).", "results_summary": "The study found that topical minoxidil (2% solution) elicited a mild erectile response in non-paralytic patients, but the evidence was insufficient to confirm its effectiveness. Combination therapy and modern formulations were suggested as promising future options.", "population_specificity": "Men with erectile dysfunction, including paralytic patients.", "effective_dosage": "2% minoxidil solution (frequency not specified).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:05.244038+00:00"}
{"study_id": 74641, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of finasteride, including its combination with minoxidil, for treating female pattern hair loss (FPHL) in normoandrogenic women.", "results_summary": "The study found that 5 mg of oral finasteride per day, especially when combined with topical estradiol and minoxidil, was effective in treating FPHL. Topical finasteride was also noted to be more effective than other topical formulas for hair loss.", "population_specificity": "Normoandrogenic women with female pattern hair loss (FPHL), particularly those in the menopausal age group.", "effective_dosage": "5 mg oral finasteride daily (minoxidil dosage not specified).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:06.728139+00:00"}
{"study_id": 74643, "supplement_id": 1344, "safety_score": "80", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy and safety of standardized non-activated PRP injections against topical minoxidil in treating moderate androgenetic alopecia in men.", "results_summary": "At week 24, 56% of participants responded to minoxidil, compared to 38% for PRP. Side effects were noted to occur more frequently with PRP than minoxidil.", "population_specificity": "Men aged 20-50 with Grade III and IV (Modified Hamilton-Norwood) androgenetic alopecia.", "effective_dosage": "5% Minoxidil applied twice daily for 6 months.", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:07.182679+00:00"}
{"study_id": 74644, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the efficacy of fractional laser treatment combined with minoxidil or cortisol compared to monotherapy in treating alopecia areata.", "results_summary": "The study found that fractional laser combined with minoxidil was more effective than minoxidil alone (RR 1.32, 95% CI 1.17-1.49, p < 0.00001). Fractional laser alone also showed significant efficacy compared to cortisol alone (RR 1.86, 95% CI 1.36-2.52, p < 0.00001).", "population_specificity": "Patients with alopecia areata (AA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:09.382045+00:00"}
{"study_id": 74648, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to review the effectiveness of microneedle delivery systems for Minoxidil in treating alopecia and promoting hair regrowth.", "results_summary": "The abstract indicates that Minoxidil's efficacy is unsatisfactory, but microneedle delivery improves local drug efficiency and patient compliance, achieving better therapeutic effects for hair-related diseases.", "population_specificity": "Not specified (general alopecia patients implied).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:11.868264+00:00"}
{"study_id": 74646, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to describe cases of alopecia after DRESS and evaluate the effectiveness of treatments, including topical minoxidil.", "results_summary": "The study found that topical minoxidil was used in 60% of patients with alopecia after DRESS, showing marked clinical improvement in telogen effluvium and alopecia areata within 6 months, but no regrowth in permanent alopecia cases.", "population_specificity": "10 patients with alopecia following DRESS (4 permanent alopecia, 5 telogen effluvium, 1 alopecia areata).", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:12.363979+00:00"}
{"study_id": 74647, "supplement_id": 1344, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the efficacy and safety of topical cetirizine combined with minoxidil versus minoxidil with placebo in treating female androgenetic alopecia (AGA).", "results_summary": "The study found that the combination of cetirizine and minoxidil significantly improved frontal and vertex terminal and vellus hair density, increased vertex hair shaft thickness, and was rated better by patients compared to minoxidil alone, with no significant difference in side effects.", "population_specificity": "Female patients aged 20-50 years with AGA (Sinclair II-IV).", "effective_dosage": "Not specified in the abstract.", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:13.217992+00:00"}
{"study_id": 74649, "supplement_id": 1344, "safety_score": "60", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to review the development and effectiveness of nanocarrier systems for Minoxidil to improve its therapeutic outcomes and reduce adverse effects compared to conventional formulations.", "results_summary": "The study found that encapsulating Minoxidil in nanocarriers enhances drug delivery to hair follicles, creates reservoirs for controlled release, and improves therapeutic efficacy while reducing side effects like erythema and dermatitis. However, data on final dosage forms and clinical applications remain limited.", "population_specificity": "Individuals with androgenic alopecia (both males and females).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:13.272690+00:00"}
{"study_id": 74645, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to review the current evidence on the use of minoxidil for treating pediatric androgenetic alopecia.", "results_summary": "The abstract suggests that topical and oral minoxidil may be very useful for treating pediatric androgenetic alopecia, though no specific efficacy data or outcomes are detailed.", "population_specificity": "Children and adolescents with androgenetic alopecia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:14.535637+00:00"}
{"study_id": 74651, "supplement_id": 1344, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "To evaluate the efficacy and safety of 2% minoxidil combined with microneedling in the treatment of female pattern hair loss.", "results_summary": "The combined treatment group (minoxidil + microneedling) showed an 85% effective rate, significantly higher than the control group (45%). Hair counts were also higher in the combined group, with only mild adverse reactions reported.", "population_specificity": "Forty female patients with female pattern hair loss.", "effective_dosage": "2% minoxidil applied daily.", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:15.027727+00:00"}
{"study_id": 74650, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of minoxidil 5% solution, alone and in combination with other treatments, on alopecia areata (AA) severity compared to other therapeutic options.", "results_summary": "Minoxidil 5% solution showed a decline in SALT scores, but the combination of betamethasone-minoxidil and betamethasone-latanoprost demonstrated greater efficacy. Minoxidil alone was less effective in regrowth compared to latanoprost and betamethasone-latanoprost groups.", "population_specificity": "108 patients with AA (50% male, mean age 32.6 \u00b1 10.4 years).", "effective_dosage": "5% solution (frequency not specified).", "study_duration": "2 weeks (final assessment time not explicitly stated).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:17.351896+00:00"}
{"study_id": 74652, "supplement_id": 1344, "safety_score": "75", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the role of oral minoxidil in treating various types of alopecia, focusing on its efficacy and safety compared to topical formulations.", "results_summary": "Oral minoxidil showed promising results in treating androgenetic alopecia and female pattern hair loss, with fewer side effects and better patient compliance than topical formulations. It was effective in both non-scarring and scarring alopecia at lower dosages.", "population_specificity": "Patients with various types of alopecia, including androgenetic alopecia and female pattern hair loss.", "effective_dosage": "Lower dosage (specific amount not mentioned)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:18.808034+00:00"}
{"study_id": 74653, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to compare the effectiveness of topical cetirizine versus minoxidil for treating androgenetic alopecia (AGA).", "results_summary": "Topical cetirizine was less effective than minoxidil for improving hair density but might have a longer-lasting effect and was similarly effective in improving hair diameter.", "population_specificity": "Patients with androgenetic alopecia (AGA).", "effective_dosage": "Not specified for minoxidil (only 1% cetirizine was detailed).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:19.689257+00:00"}
{"study_id": 74654, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to review nonsurgical treatments for androgenetic alopecia, including Minoxidil, and their gender-specific considerations.", "results_summary": "The abstract mentions Minoxidil as one of three FDA-approved treatments for androgenetic alopecia, suggesting its efficacy, but does not provide specific results. Platelet-rich plasma injections are noted as a promising adjunct therapy.", "population_specificity": "Men and women with androgenetic alopecia.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:21.155261+00:00"}
{"study_id": 74655, "supplement_id": 1344, "safety_score": "65", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the efficacy and safety of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia (AGA).", "results_summary": "Oral minoxidil was found to be effective for hair growth, acting through multiple pathways, but caused dose-dependent hypertrichosis and cardiovascular symptoms. It ranked below dutasteride and finasteride in efficacy.", "population_specificity": "Patients with androgenetic alopecia (AGA), primarily male.", "effective_dosage": "5 mg/d and 0.25 mg/d", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:21.207245+00:00"}
{"study_id": 74656, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether concentrations of minoxidil greater than 5% provide additional clinical benefit for treating androgenetic alopecia (AGA).", "results_summary": "The study reviewed literature on higher minoxidil concentrations for AGA, noting that 5% minoxidil is superior to 2%, but evidence for concentrations above 5% remains unclear.", "population_specificity": "Patients with androgenetic alopecia (AGA).", "effective_dosage": "2% and 5% minoxidil solutions (higher concentrations not specified).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:21.940168+00:00"}
{"study_id": 74657, "supplement_id": 1344, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the clinical and dermoscopic efficacy of topical minoxidil 5% gel versus MTX 1% gel in treating localized alopecia areata.", "results_summary": "Minoxidil showed significantly better clinical improvement than MTX after 6 weeks (16% vs. 0%) and comparable efficacy after 12 weeks (52% vs. 36%). Dermoscopic findings indicated minoxidil had higher frequencies of broken hair and black dots at 6 weeks but lower vellus hair at 12 weeks compared to MTX.", "population_specificity": "50 patients with localized alopecia areata, divided into two groups of 25 each.", "effective_dosage": "Topical minoxidil 5% gel (frequency not specified).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:24.053199+00:00"}
{"study_id": 74658, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether combining botulinum toxin A injections with finasteride and minoxidil enhances treatment efficacy for androgenic alopecia compared to finasteride and minoxidil alone.", "results_summary": "The study found that hair density significantly increased after 3 and 6 months of treatment with finasteride and minoxidil, with further improvement on the side receiving botulinum toxin A injections. The combined treatment had a 77.5% response rate with no significant side effects reported.", "population_specificity": "37 patients with androgenic alopecia.", "effective_dosage": "Not specified for minoxidil.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:24.140343+00:00"}
{"study_id": 74659, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review the synthesis of pyrimidine analogs, including minoxidil, under microwave irradiation and their therapeutic potentials.", "results_summary": "The abstract mentions minoxidil as an antihypertensive drug among other pyrimidine-based compounds but does not provide specific results regarding its effects.", "population_specificity": "Not specified", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:24.571468+00:00"}
{"study_id": 74661, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to review the potential benefits of minoxidil in treating hair loss associated with SARS-CoV-2 infection (HLASCI), particularly focusing on telogen effluvium (TE).", "results_summary": "The study suggested that topical minoxidil may be beneficial for HLASCI, particularly for TE, but emphasized the need for future clinical research to confirm these observations.", "population_specificity": "Individuals experiencing hair loss after SARS-CoV-2 infection, including those with telogen effluvium, androgenetic alopecia, and alopecia areata.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:27.063255+00:00"}
{"study_id": 74663, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review experimental studies on alopecia treatments, including Minoxidil, to identify effective herbal combinations and their mechanisms of action.", "results_summary": "The abstract mentions Minoxidil as an FDA-approved drug for androgenetic alopecia but highlights its adverse effects and high cost as limitations. The study focuses more on screening traditional Chinese medicine combinations for alopecia treatment.", "population_specificity": "Patients with androgenetic alopecia (AGA) and alopecia areata (AA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:27.592712+00:00"}
{"study_id": 74664, "supplement_id": 1344, "safety_score": "85", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy and safety of a mixed preparation (piperine, capsaicin, and curcumin) versus 5% minoxidil in treating alopecia areata.", "results_summary": "Both treatments showed statistically significant hair regrowth, with minoxidil having a slightly higher effective rate (70%) compared to the mixed preparation (63.33%). Adverse effects were temporary and non-serious.", "population_specificity": "60 patients with alopecia areata, divided into two groups.", "effective_dosage": "5% minoxidil applied once daily.", "study_duration": "3 months (12 weeks).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:29.357309+00:00"}
{"study_id": 74666, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy of combination therapy (topical 2% flutamide plus 5% minoxidil) versus 5% minoxidil alone in treating androgenetic alopecia.", "results_summary": "The study found that the combination of topical flutamide and minoxidil was significantly more effective than minoxidil alone in improving hair density, hair thickness, and patient satisfaction (p < 0.05).", "population_specificity": "40 patients with androgenetic alopecia.", "effective_dosage": "5% minoxidil (frequency not specified).", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:30.291456+00:00"}
{"study_id": 74665, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate whether topical finasteride is a safe and effective treatment for male and female pattern hair loss.", "results_summary": "The study found that topical 0.25% w/w finasteride spray had similar efficacy to oral finasteride 1 mg after 24 weeks of use, with mean hair count increases of 20.2 vs. 21.1 hairs/cm\u00b2, respectively. Topical finasteride may be an alternative for those concerned about systemic side effects of oral finasteride.", "population_specificity": "Individuals with male and female pattern hair loss (androgenetic alopecia).", "effective_dosage": "Topical 0.25% w/w finasteride spray (1-4 sprays; 50-200 \u03bcl/day).", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:31.434560+00:00"}
{"study_id": 74669, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to assess the efficacy of a new coadjuvant oral and topical therapy containing natural substances for treating androgenetic alopecia (AGA) in comparison to conventional treatments like minoxidil.", "results_summary": "The study found clinically visible improvement in hair loss after three and six months of treatment, with statistically significant increases in TrichoScan measurements, suggesting the natural complex could be a valid alternative or coadjuvant to minoxidil or finasteride.", "population_specificity": "Sixty individuals with mild-to-moderate female and male androgenetic alopecia.", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:32.743210+00:00"}
{"study_id": 74670, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to review the potential of natural products as alternatives or adjuncts to conventional treatments like minoxidil for male androgenetic alopecia.", "results_summary": "The study suggests that topical minoxidil requires long-term application for improvement, and natural products like saw palmetto, caffeine, and rosemary oil may enhance clinical outcomes when used alongside minoxidil.", "population_specificity": "Male patients with androgenetic alopecia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:33.324786+00:00"}
{"study_id": 74667, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the relative efficacy of minoxidil, dutasteride, and finasteride for treating male androgenetic alopecia (AGA).", "results_summary": "Minoxidil showed significant efficacy in increasing terminal hair count at 24 weeks (5 mg/d dose was most effective), but its effects varied by dosage and formulation. At 48 weeks, finasteride outperformed minoxidil in total and terminal hair count improvements.", "population_specificity": "Males aged 22.8 to 41.8 years with androgenetic alopecia.", "effective_dosage": "0.25 mg/d, 5 mg/d (oral), 2% solution, and 5% solution (topical).", "study_duration": "24 and 48 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:33.944608+00:00"}
{"study_id": 74671, "supplement_id": 1344, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the efficacy and side effects of minoxidil alone versus minoxidil combined with basic fibroblast growth factor (bFGF) in treating early-stage androgenetic alopecia in male patients.", "results_summary": "The combination of bFGF and minoxidil showed statistically significant improvements in hair condition and patient satisfaction compared to minoxidil alone, with no serious adverse reactions reported in either group.", "population_specificity": "80 male patients with androgenetic alopecia (Hamilton grade II-IV).", "effective_dosage": "1 ml minoxidil for external use twice a day (Group A); 3500 IU bFGF + 1 ml minoxidil for external use twice a day (Group B).", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:36.387005+00:00"}
{"study_id": 74672, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to summarize and discuss the potential of bicalutamide as a new therapy for female pattern hair loss (FPHL), comparing it to the currently FDA-approved topical minoxidil.", "results_summary": "The abstract highlights that topical minoxidil has a variable response rate for FPHL, while bicalutamide shows promise with favorable safety and tolerability, particularly for women with hyperandrogenism features.", "population_specificity": "Women with female pattern hair loss (FPHL), particularly those presenting with hyperandrogenism features like seborrhea, acne, and hirsutism.", "effective_dosage": "Not specified for minoxidil.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:37.046230+00:00"}
{"study_id": 74673, "supplement_id": 1344, "safety_score": "65", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers aimed to report cases of frontal edema resulting from mesotherapy for androgenetic alopecia (AGA) treatment, focusing on potential roles of minoxidil and dutasteride.", "results_summary": "The study found that frontal edema occurred mostly in the first two mesotherapy sessions, lasting 1-4 days, with favorable outcomes after local cold compresses. Lidocaine was the anesthetic used, and minoxidil and dutasteride were suggested as possible causative agents.", "population_specificity": "Patients undergoing mesotherapy for AGA treatment (14 cases reported).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:37.653300+00:00"}
{"study_id": 74674, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety and efficacy of platelet-rich plasma (PRP) compared to traditional treatments like Minoxidil for female androgenetic alopecia (F-AGA).", "results_summary": "The study found PRP to be a safe and effective alternative to Minoxidil for F-AGA, with positive effects reported in 8% of analyzed articles and no major side effects.", "population_specificity": "Female patients with androgenetic alopecia (F-AGA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:37.719333+00:00"}
{"study_id": 74675, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to compare the effectiveness of intralesional steroid with QR678 Neo versus intralesional steroid with placebo in treating patchy hair loss in alopecia areata patients.", "results_summary": "Group B (intralesional steroid with QR678 Neo) showed marked improvement in global assessment scores and significant reduction in hair loss markers like black dots and broken hairs after 6 months, with higher patient satisfaction compared to Group A.", "population_specificity": "20 participants aged 20-50 years with nonscarring patchy hair loss.", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:40.372569+00:00"}
{"study_id": 74678, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 50, "study_goal": "The researchers aimed to review treatment options for valproate-associated hair abnormalities, including the potential use of minoxidil.", "results_summary": "The study mentions topical minoxidil as a treatment option for valproate-induced hair loss but notes a lack of evidence supporting its efficacy. No specific results regarding minoxidil's effectiveness are provided.", "population_specificity": "Individuals experiencing hair abnormalities due to valproate treatment.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:41.672874+00:00"}
{"study_id": 74677, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of microneedling, both as a monotherapy and in combination with topical minoxidil 5%, for treating androgenetic alopecia (AGA).", "results_summary": "Microneedling monotherapy significantly increased total hair count more than topical minoxidil 5% alone. Combining microneedling with topical minoxidil 5% further enhanced hair count compared to microneedling alone.", "population_specificity": "Patients with androgenetic alopecia (AGA).", "effective_dosage": "Topical minoxidil 5% (frequency not specified).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:41.806985+00:00"}
{"study_id": 74676, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to highlight how Minoxidil's side effect of hirsutism is utilized to treat alopecia and baldness, despite its primary use for systemic hypertension.", "results_summary": "The study notes that Minoxidil, primarily used for hypertension, has a well-known side effect of hirsutism, which is leveraged to treat alopecia and baldness. It positions Minoxidil as an example of cardiovascular medications repurposed for non-cardiovascular conditions.", "population_specificity": "Not specified (general discussion of cardiovascular medication effects).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:42.637950+00:00"}
{"study_id": 74682, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to explore the role of nanotechnology-based drug delivery systems, such as Minoxidil, in improving the management of alopecia compared to conventional topical treatments.", "results_summary": "The study suggests that nanoparticulate-based delivery systems enhance drug permeability and efficacy compared to conventional methods, potentially improving alopecia treatment outcomes. However, specific results on Minoxidil's effectiveness are not detailed in the abstract.", "population_specificity": "People aged 30-40 years experiencing alopecia.", "effective_dosage": "Not available", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:45.148376+00:00"}
{"study_id": 74683, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 40, "quality_score": 60, "study_goal": "The researchers aimed to review the efficacy and limitations of available treatments, including minoxidil, for alopecia areata (AA).", "results_summary": "The study found that minoxidil, along with other treatments like corticosteroids and immunomodulators, has limited efficacy for AA, with high recurrence rates and adverse effects, especially in severe cases.", "population_specificity": "Patients with alopecia areata, including those with patchy, totalis, or universalis forms.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:45.531412+00:00"}
{"study_id": 74680, "supplement_id": 1344, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the efficacy and safety of sublingual minoxidil as a targeted treatment for hair loss, focusing on optimized drug delivery to enhance efficacy and reduce systemic adverse effects.", "results_summary": "The study found that sublingual minoxidil is a promising therapy for hair loss, with optimized drug delivery improving efficacy and reducing systemic adverse effects. It also highlighted that Janus kinase inhibitors help maintain hair follicles and promote regrowth in alopecia areata.", "population_specificity": "Humans with hair loss conditions, including alopecia areata.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:45.898867+00:00"}
{"study_id": 74685, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether applying a SULT1A1 enzyme booster prior to daily 5% minoxidil treatment improves hair regrowth in male androgenic alopecia patients.", "results_summary": "75% of subjects using the SULT1A1 adjuvant with minoxidil regrew hair after 60 days, compared to 33% in the placebo group (p = 0.023). The study concluded that the adjuvant improved hair regrowth in this cohort.", "population_specificity": "24 males with androgenic alopecia (Norwood scale average 4.4, range 2-6).", "effective_dosage": "5% topical minoxidil daily.", "study_duration": "60 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:49.792721+00:00"}
{"study_id": 74689, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the role of antihypertensive agents, including minoxidil, in managing hypertension in children and adolescents with genetic conditions like Turner syndrome, neurofibromatosis type 1, and William Syndrome.", "results_summary": "The study suggests that minoxidil, as an agent inhibiting oxidative stress, should be considered for hypertension management in these populations, even in the absence of overt hypertension, due to its potential vascular benefits.", "population_specificity": "Children and adolescents with Turner syndrome, neurofibromatosis type 1, or William Syndrome.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:50.214960+00:00"}
{"study_id": 74687, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy and safety of topical cetirizine 1% versus minoxidil 5% solutions in treating male androgenetic alopecia over 16 weeks.", "results_summary": "Minoxidil 5% significantly increased total and vellus hair density and the percentage of hair in the anagen phase after 16 weeks, outperforming cetirizine. These improvements diminished after 8 weeks of placebo use.", "population_specificity": "40 men aged 18-49 with androgenetic alopecia.", "effective_dosage": "5% solution applied twice daily.", "study_duration": "16 weeks of treatment followed by 8 weeks of placebo.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:51.406298+00:00"}
{"study_id": 74691, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to systematically review placebo-controlled or comparative therapeutic trials for the treatment of idiopathic chilblains, not specifically Minoxidil.", "results_summary": "The abstract does not mention Minoxidil or its effects, focusing instead on a review of treatments for idiopathic chilblains, primarily oral nifedipine.", "population_specificity": "Patients with idiopathic chilblains (cold-induced inflammatory condition).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:53.694595+00:00"}
{"study_id": 74690, "supplement_id": 1344, "safety_score": "75", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the efficacy and safety of low-dose oral minoxidil as an alternative to topical minoxidil for various hair disorders.", "results_summary": "Oral minoxidil was found to be a successful and well-tolerated alternative for hair loss, with efficacy demonstrated across multiple hair disorders, including androgenetic alopecia and scarring alopecias. Different dosing regimens were effective, with women requiring lower doses (0.25-2.5 mg daily) and men requiring higher doses (1.25-5 mg daily).", "population_specificity": "Patients with various hair disorders, including androgenetic alopecia, telogen effluvium, tractional alopecia, postchemotherapy-induced alopecia, monilethrix, loose anagen hair syndrome, alopecia areata, and scarring alopecias (frontal fibrosing alopecia and lichen planopilaris).", "effective_dosage": "0.25 to 5 mg daily, varying by condition and gender.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:56.083912+00:00"}
{"study_id": 74694, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 44, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of various treatments, including topical minoxidil, for pediatric alopecia areata.", "results_summary": "The study found that topical minoxidil had a response rate of 44% (4/9) in pediatric patients with alopecia areata, indicating modest efficacy compared to other treatments.", "population_specificity": "Children \u226418 years old with alopecia areata.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:57.280648+00:00"}
{"study_id": 74693, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to identify and rank the best treatments for alopecia areata, including minoxidil, using a systematic review and network meta-analysis.", "results_summary": "Minoxidil plus topical corticosteroids was ranked among the top treatments for alopecia areata, though the study could not definitively identify the best treatment due to independent loops and wide confidence intervals.", "population_specificity": "3149 patients across 54 RCTs, including those with alopecia areata.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:57.469448+00:00"}
{"study_id": 74695, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the clinical efficacy of pumpkin seed oil (PSO) with minoxidil 5% foam in treating female pattern hair loss (FPHL).", "results_summary": "Minoxidil 5% foam showed significant reductions in hair shaft diversity and vellus hairs, with increased upright regrowing hairs, indicating effectiveness in treating FPHL. The study found comparable efficacy between minoxidil and PSO, though minoxidil had stronger statistical significance in some measures.", "population_specificity": "Female patients with female pattern hair loss (FPHL).", "effective_dosage": "5% foam (frequency not specified).", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:00.846115+00:00"}
{"study_id": 74696, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to evaluate the therapeutic effects of platelet-rich plasma (PRP) as a co-adjuvant therapy in androgenetic alopecia, comparing different administration methods.", "results_summary": "PRP-treated patients showed statistically significant increases in hair density and diameter compared to the control group, with microneedling enhancing these results. The addition of PRP with microneedling improved efficacy and shortened the time needed for optimal improvement.", "population_specificity": "126 patients with androgenetic alopecia (84 receiving PRP, 42 as controls).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:01.727056+00:00"}
{"study_id": 74699, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to summarize evidence-based and expert-based recommendations for the treatment of androgenetic alopecia, including the use of topical minoxidil.", "results_summary": "The abstract highlights minoxidil as a medical treatment option for androgenetic alopecia, indicating its inclusion in treatment guidelines, but does not provide specific efficacy data.", "population_specificity": "Men and women with androgenetic alopecia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:04.817217+00:00"}
{"study_id": 74697, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 68, "study_goal": "The researchers aimed to evaluate the efficacy, safety, and therapeutic durability of platelet-rich plasma (PRP) in treating various forms of alopecia, with a focus on its simultaneous use with Minoxidil.", "results_summary": "The simultaneous use of PRP and Minoxidil demonstrated the highest rate of improvement and satisfaction in hair growth and thickness. Efficacy varied by alopecia type, with the highest reported improvement at 76% for alopecia areata and 42.75% for androgenetic alopecia.", "population_specificity": "Patients with various forms of alopecia, including alopecia areata and androgenetic alopecia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:05.137633+00:00"}
{"study_id": 74698, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effectiveness of topical minoxidil 5% gel, spironolactone 1% gel, and their combination in treating androgenetic alopecia (AGA).", "results_summary": "Minoxidil 5% gel showed clinical improvement in 90% of patients, spironolactone 1% gel in 80%, and the combination in 100%. Histopathological results confirmed increased anagen hair and reduced telogen/vellus hair, with the combination being most effective.", "population_specificity": "60 patients diagnosed with androgenetic alopecia (AGA).", "effective_dosage": "Minoxidil 5% gel (frequency not specified).", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:06.780070+00:00"}
{"study_id": 74679, "supplement_id": 1344, "safety_score": "70", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to compare the therapeutic effects and side effects of oral minoxidil (0.25 mg tablets) versus topical minoxidil (2% solution) in treating female pattern hair loss (FPHL).", "results_summary": "The study found that oral minoxidil improved hair diameter and density after 9 months of treatment, though specific comparative efficacy data between oral and topical forms were not fully detailed in the abstract. Side effects like skin allergies were noted as a limitation for topical use.", "population_specificity": "72 women with female pattern hair loss (FPHL).", "effective_dosage": "Oral minoxidil 0.25 mg tablets (Group 1) and topical minoxidil 2% solution (Group 2).", "study_duration": "9 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:07.028525+00:00"}
{"study_id": 74700, "supplement_id": 1344, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and safety of intradermal injections of 0.5% minoxidil for treating female androgenetic alopecia compared to a placebo.", "results_summary": "The study found that intradermal minoxidil significantly improved the terminal-to-vellus hair ratio, increased anagen hairs, and enhanced hair loss and volume compared to placebo, with a good safety profile.", "population_specificity": "54 women diagnosed with female androgenetic alopecia.", "effective_dosage": "0.5% minoxidil intradermal injections (frequency not specified).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:08.778611+00:00"}
{"study_id": 74702, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness and safety of a topical herbal solution with 5% minoxidil in treating mild to moderate androgenetic alopecia in men.", "results_summary": "The herbal solution combined with minoxidil (MTS + THS) showed significantly greater improvement in hair diameter compared to minoxidil alone (MTS) after 36 weeks. Hair density increased in both groups, but the increase was only significant in the MTS + THS group.", "population_specificity": "24 healthy males (mean age 33.04) with mild to moderate androgenetic alopecia.", "effective_dosage": "1 ml of topical solution applied twice daily (morning and evening).", "study_duration": "9 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:10.718306+00:00"}
{"study_id": 74704, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to compare the clinical efficacy of PRP therapy, minoxidil, and their combination in treating androgenetic alopecia (AGA) in men.", "results_summary": "PRP treatment was more effective than minoxidil therapy alone, but the combination of PRP and minoxidil showed promising results for AGA treatment. Minoxidil improved hair morphology but was less effective than PRP.", "population_specificity": "69 men with androgenetic alopecia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:12.489881+00:00"}
{"study_id": 74692, "supplement_id": 1344, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the safety of low-dose oral minoxidil (LDOM) for treating hair loss in a large patient cohort.", "results_summary": "LDOM demonstrated a good safety profile, with hypertrichosis being the most common adverse effect (15.1%). Systemic adverse effects were rare (1.7% discontinuation rate), and no life-threatening effects were observed.", "population_specificity": "1404 patients (943 women, 461 men; mean age 43 years) with various types of alopecia.", "effective_dosage": "Dose was titrated in 1065 patients (specific amounts not provided).", "study_duration": "At least 3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:14.111438+00:00"}
{"study_id": 74705, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to summarize the available literature on microneedling (MN) alone or combined with other therapies, including minoxidil, for treating androgenetic alopecia (AGA).", "results_summary": "The abstract highlights that topical minoxidil is FDA-approved for AGA treatment and suggests that microneedling may enhance hair density, thickness, and quality, especially when combined with other therapies like minoxidil. However, no standardized protocol for MN in hair loss exists yet.", "population_specificity": "Men and women with androgenetic alopecia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:15.055350+00:00"}
{"study_id": 74707, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the role of minoxidil as part of a stepwise pharmacologic treatment for resistant hypertension, particularly as a final step in achieving blood pressure control.", "results_summary": "The study suggests that switching to a minoxidil-based regimen can be a non-evidence-based but final step in managing resistant hypertension when other treatments fail. However, the abstract does not provide specific efficacy data or outcomes for minoxidil alone.", "population_specificity": "Patients with resistant hypertension (BP \u2265130/80 mmHg on \u22653 antihypertensive agents or BP <130/80 mmHg on \u22654 antihypertensive drugs).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:15.748716+00:00"}
{"study_id": 74686, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether topical minoxidil could be an effective treatment for autosomal recessive woolly hair/hypotrichosis (ARWH) due to LIPH mutations.", "results_summary": "The study suggests that topical minoxidil might be a promising treatment for ARWH caused by LIPH mutations, though sufficiently effective treatments are not yet established. The abstract does not provide detailed efficacy data.", "population_specificity": "Patients with autosomal recessive woolly hair/hypotrichosis (ARWH) due to LIPH mutations.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:22.804152+00:00"}
{"study_id": 74703, "supplement_id": 1344, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to compare the effectiveness of various interventions, including minoxidil, in preventing chemotherapy-induced alopecia (CIA).", "results_summary": "Minoxidil was ranked fifth in efficacy among the interventions studied, behind scalp cooling, scalp compression with tourniquets, and topical and oral Chinese medicinal herbs, but more effective than usual care.", "population_specificity": "Patients undergoing chemotherapy and experiencing or at risk of chemotherapy-induced alopecia.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:32.424586+00:00"}
{"study_id": 76542, "supplement_id": 1374, "safety_score": "75", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to review existing literature on facial neuromuscular electrical stimulation (fNMES), establish safety and reporting recommendations, and explore its potential applications in psychology and neuroscience.", "results_summary": "The study systematically reviewed fNMES parameters, highlighted variability in current practices, and provided safety recommendations. It also introduced a free webpage for visualizing and verifying fNMES parameters.", "population_specificity": "Not specified (general focus on psychological and neuroscience research applications).", "effective_dosage": "Not specified (reviewed varying parameters like frequency, amplitude, duration, and electrode size).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:40.945785+00:00"}
{"study_id": 76549, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effectiveness of Neuromuscular Electrical Stimulation (NMES) on improving glycemic control in populations with physical impairments and/or metabolic disorders.", "results_summary": "The meta-analysis of nine randomized controlled trials involving 180 participants found that NMES significantly improved glycemic control, particularly in middle-aged and elderly populations with type 2 diabetes, obesity, and spinal cord injury. The intervention lowered fasting blood glucose and showed consistent benefits across various glycemic control measures.", "population_specificity": "Middle-aged and elderly individuals with type 2 diabetes, obesity, and spinal cord injury.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:41.219985+00:00"}
{"study_id": 76539, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effectiveness of non-invasive transcutaneous electrical stimulation therapies, including TENS and Ta-VNS, in improving walking distance and pain in patients with peripheral arterial occlusive disease (PAD).", "results_summary": "The study found that TENS on the calves or trans-auricular vagus nerve stimulation improved walking distance in PAD patients with intermittent claudication, though the overall positive effects were limited and mechanisms remain not fully understood.", "population_specificity": "Patients with PAD of the lower limbs, including those with intermittent claudication or critical limb ischemia (CLI).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:41.331236+00:00"}
{"study_id": 76550, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of an 8-week multimodal exercise program (including NMES) on postural balance in COPD patients enrolled in pulmonary rehabilitation, compared to other interventions.", "results_summary": "The study will investigate the effects of NMES combined with pulmonary rehabilitation on static and dynamic postural balance, muscle strength, and other outcomes, but results are not yet provided in the abstract.", "population_specificity": "Patients with chronic obstructive pulmonary disease (COPD) enrolled in a pulmonary rehabilitation program.", "effective_dosage": "Two sessions per week for 8 weeks (specific NMES parameters not detailed).", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:41.541021+00:00"}
{"study_id": 76533, "supplement_id": 1374, "safety_score": "85", "efficacy_score": 78, "quality_score": 65, "study_goal": "The researchers aimed to investigate the effectiveness of conservative non-pharmacological interventions, including neuromuscular electrical stimulation, for managing physical symptoms in muscular dystrophies.", "results_summary": "For adults with Facioscapulohumeral dystrophy (FSHD), neuromuscular electrical stimulation reduced pain intensity with an effect size range of 1.58 to 2.33. The study concluded that strength training, including neuromuscular electrical stimulation, may improve perceived exertion, balance, and well-being in muscular dystrophies.", "population_specificity": "Adults with Facioscapulohumeral dystrophy (FSHD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:41.605948+00:00"}
{"study_id": 76546, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effectiveness of NMES in improving functional status and diaphragm function in patients with severe acute pancreatitis complicated by acute respiratory distress syndrome.", "results_summary": "The study protocol outlines a randomized controlled trial to assess NMES effects on muscle power, lower extremity circumference, grip strength, activities of daily living, and diaphragm function, with follow-up measurements post-discharge. Results are pending as the abstract describes the study protocol rather than outcomes.", "population_specificity": "Patients with severe acute pancreatitis complicated by acute respiratory distress syndrome (n=80).", "effective_dosage": "1 hour per day for 7 days.", "study_duration": "7 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:41.608225+00:00"}
{"study_id": 76548, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the rehabilitative mechanism of sequential 4-channel NMES compared to conventional 2-channel NMES using kinematic analysis of swallowing-related hyoid bone movement.", "results_summary": "The 4-channel NMES group showed significant improvements in hyoid bone movement parameters (vertical and horizontal distances, time intervals, and velocity) compared to pretreatment data and outperformed the 2-channel NMES group in several key metrics. The 2-channel NMES group showed limited improvements and some declines in Euclidean distance and velocity.", "population_specificity": "17 subjects with dysphagia (11 in the 4-channel NMES group, 6 in the 2-channel NMES group).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:41.678813+00:00"}
{"study_id": 76534, "supplement_id": 1374, "safety_score": "85", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of neuromuscular electrical stimulation (NMES) on lower limb muscle strength and health-related quality of life (HR-QOL) after thoracic and abdominal surgery.", "results_summary": "NMES slightly increased lower limb muscle strength in cardiovascular surgery patients, with minor adverse events (e.g., hypotension, pain, muscle discomfort) reported in seven patients. HR-QOL was measured in two studies but not pooled due to heterogeneity.", "population_specificity": "Patients recovering from thoracic and abdominal surgery, including cardiovascular, pulmonary, digestive system, and other surgeries (915 participants across 18 randomized controlled trials).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:42.119273+00:00"}
{"study_id": 76552, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to summarize the usefulness of VitalStim\u00ae therapy (NMES) for treating dysphagia and identify barriers to its use in Pakistan.", "results_summary": "The abstract indicates that VitalStim\u00ae therapy improves swallowing function in dysphagia patients, but it does not provide specific efficacy data or statistical outcomes. Barriers to its use in Pakistan are mentioned but not detailed.", "population_specificity": "Patients with dysphagia due to various causes, including stroke, head injury, Alzheimer's, dementia, muscular dystrophy, and cerebral palsy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:49.418627+00:00"}
{"study_id": 76553, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of neuromuscular electrical stimulation as an adaptation to exercise training for patients with COPD, focusing on its potential benefits for cardiovascular and muscular impairments.", "results_summary": "The abstract suggests that neuromuscular electrical stimulation is an important training modality for COPD patients, potentially improving movement efficiency and accommodating cardiovascular and ventilatory impairments, though specific results are not detailed.", "population_specificity": "Patients with stable but symptomatic COPD, those who have suffered exacerbations, and patients waiting for or who have received lung volume reduction or lung transplantation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:49.504150+00:00"}
{"study_id": 76554, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness of Neuromuscular Electrical Stimulation (NMES) with conventional dysphagia therapy and transcranial direct current stimulation (tDCS) in treating post-stroke dysphagia.", "results_summary": "NMES combined with conventional therapy showed better improvement than conventional therapy alone, though not statistically superior to tDCS. The most effective outcomes were achieved when NMES, tDCS, and conventional therapy were combined.", "population_specificity": "40 acute stroke patients (18 females, 22 males, mean age 65.8 \u00b1 11.9).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:49.885193+00:00"}
{"study_id": 76551, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether NMES combined with early rehabilitation improves diaphragm and skeletal muscle function in mechanically ventilated patients.", "results_summary": "The study found that NMES combined with early rehabilitation significantly improved diaphragmatic thickening fraction, reduced muscle atrophy, shortened mechanical ventilation duration, and enhanced muscle strength compared to early rehabilitation alone.", "population_specificity": "80 mechanically ventilated patients with respiratory failure.", "effective_dosage": "Not specified", "study_duration": "Measurements taken at the first day of MV, the 3rd and 7th day of intervention, and the day of ICU discharge.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:49.941779+00:00"}
{"study_id": 76558, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize major advances in transcutaneous motor-level electrical stimulation, focusing on its applications for investigating neuromuscular function (EST) and improving strength/mass (NMES).", "results_summary": "The study highlights key advances in optimizing motor unit recruitment during electrically-evoked contractions, emphasizing the influence of stimulation site and type. It underscores the utility of EST for research and NMES for therapeutic benefits in various populations.", "population_specificity": "Various populations (not specified in detail).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:50.156871+00:00"}
{"study_id": 76555, "supplement_id": 1374, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of fixed transverse textile electrodes (TTE) knitted into a sock versus motor point placed standard gel electrodes (MPE) on peak venous velocity (PVV) and discomfort during calf neuromuscular electrical stimulation (calf-NMES).", "results_summary": "Both TTE and MPE significantly increased PVV in the popliteal and femoral veins, with TTE showing higher increases in the popliteal vein. TTE required higher current and caused more discomfort at plantar flexion but achieved comparable hemodynamic effects to MPE.", "population_specificity": "Ten healthy participants.", "effective_dosage": "Increasing intensity until plantar flexion (ML I) and an additional mean 4 mA intensity (ML II).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:50.798442+00:00"}
{"study_id": 76556, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of traditional intrinsic foot muscle training (TRAIN) versus training combined with neuromuscular electrical stimulation (NMES) on dynamic balance, foot posture, and perceived workload.", "results_summary": "NMES showed early improvements in dynamic balance and foot posture at 2 weeks, but no significant differences between TRAIN and NMES groups were observed by 4 weeks. Perceived workload decreased over time, with no difference between groups.", "population_specificity": "39 participants (specific demographics not detailed in the abstract).", "effective_dosage": "NMES was applied during the first 2 weeks of training (exact parameters not specified).", "study_duration": "4 weeks of training (NMES applied during the first 2 weeks), with follow-up at 8 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:51.069539+00:00"}
{"study_id": 76557, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of different types and frequencies of physiotherapy, including Neuromuscular Electrical Stimulation (NEMS), on ventilator weaning in ICU patients.", "results_summary": "The study found that early rehabilitation, particularly progressive mobility, was most effective in reducing ventilator duration, while high-frequency NEMS did not show a significant advantage over moderate frequency. NEMS was included as one of the treatment types but was not highlighted as the most effective intervention.", "population_specificity": "Patients in the intensive care unit (ICU) requiring ventilator support.", "effective_dosage": "NEMS dosage was categorized as high (>60 minutes/day), moderate (30-60 minutes/day), or low (<30 minutes/day).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:51.152042+00:00"}
{"study_id": 76563, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the short-term respiratory effects of neuromuscular electrical stimulation (NMES) in critically ill ICU patients.", "results_summary": "NMES significantly reduced the duration of mechanical ventilation, decreased weaning trial failures, shortened ICU stays, and lowered mortality compared to the control group.", "population_specificity": "Critically ill patients in the intensive care unit (ICU).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:57.296249+00:00"}
{"study_id": 76561, "supplement_id": 1374, "safety_score": "85", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to summarize the evidence on the feasibility and effectiveness of combining neuromuscular electrical stimulation (NMES) with nutritional therapy for individuals with or at risk of sarcopenia.", "results_summary": "The review found that combined NMES and nutritional therapy interventions may be feasible and effective for increasing skeletal muscle mass, though most studies were of low to moderate quality. The results suggest potential benefits but highlight the need for higher-quality RCTs with larger sample sizes.", "population_specificity": "Older adults with sarcopenic obesity, patients in intensive care, and patients with cancer.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:58.151467+00:00"}
{"study_id": 76560, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness of various therapies, including Neuromuscular Electrical Stimulation (NMES), for improving dysphagia in post-stroke patients.", "results_summary": "NMES was found to be superior to the control in improving dysphagia, but no therapy, including NMES, showed superiority in reducing case fatality or chest infection/pneumonia. The study concluded that commonly used therapies for post-stroke dysphagia had similar efficacies.", "population_specificity": "Post-stroke patients with dysphagia (2,993 patients across 42 randomized controlled trials).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:58.216364+00:00"}
{"study_id": 76562, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to analyze the protocol characteristics of neuromuscular electrical stimulation (NMES) studies targeting afferent pathways in the plantar flexors and compare stimulation methods (triceps surae vs. tibial nerve).", "results_summary": "The review found that tibial nerve stimulation used a wider range of frequencies (5-100 Hz) compared to triceps surae stimulation (20-200 Hz), with pulse durations ranging from 0.2 to 1 ms for both. It highlighted the need for future studies to explore more varied stimulation attributes and address methodological issues like efficacy and discomfort reporting.", "population_specificity": "Healthy adults", "effective_dosage": "Frequencies ranged from 5-200 Hz, pulse durations from 0.2-1 ms", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:00.035309+00:00"}
{"study_id": 76565, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether adding blood flow restriction (BFR) to neuromuscular electrical stimulation (NMES) would enhance improvements in strength, pain, and physical performance in service members with patellofemoral pain syndrome (PFPS).", "results_summary": "NMES combined with exercise improved knee extensor and hip strength, pain, and physical performance over 9 weeks, but adding BFR did not provide additional benefits. Improvements were positively correlated with the number of BFR-NMES sessions and NMES usage time.", "population_specificity": "Military service members with patellofemoral pain syndrome (PFPS).", "effective_dosage": "In-clinic BFR-NMES was performed twice weekly; at-home NMES with exercise and exercise alone were done on alternating days.", "study_duration": "9 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:00.992814+00:00"}
{"study_id": 76564, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the evoked torque, current intensity, neuromuscular efficiency, and discomfort between pulsed current and kilohertz frequency alternating current in healthy individuals.", "results_summary": "Pulsed currents generated higher evoked torque than kilohertz frequency alternating currents, with similar discomfort levels. The 2 ms pulsed current showed lower current intensity and higher neuromuscular efficiency compared to the other currents.", "population_specificity": "Thirty healthy men (mean age 23.2 years).", "effective_dosage": "Four current settings: two kilohertz frequency alternating currents (2.5 kHz carrier frequency, 0.4 ms pulse duration, 100 Hz burst frequency, 20% and 50% burst duty cycles, 2 and 5 ms burst durations) and two pulsed currents (100 Hz pulse frequency, 2 and 0.4 ms pulse durations).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:01.401145+00:00"}
{"study_id": 76559, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the therapeutic benefits of combined and single neurostimulation therapies, including Neuromuscular Electrical Stimulation (NMES), for post-stroke dysphagia rehabilitation.", "results_summary": "NMES combined with traditional dysphagia therapy (TDT) showed very large effects in improving swallowing function and medium effects in reducing pharyngeal transit time (PTT). NMES alone also demonstrated significant benefits, though slightly less pronounced than combined therapies.", "population_specificity": "Post-stroke dysphagia (PSD) patients (2,250 participants across 50 randomized controlled studies).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:01.707223+00:00"}
{"study_id": 76566, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the rehabilitation effects of Neuromuscular Electrical Stimulation (NMES) on volumetric muscle loss (VML) in subjects with spinal cord injury (SCI).", "results_summary": "The study found that electrical stimulation and treadmill training were effective in reducing VML in individuals with SCI. The systematic review highlighted the need for varied rehabilitation approaches to prevent VML in subacute and chronic SCI phases.", "population_specificity": "Humans and animals affected by traumatic spinal cord injury.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:02.555954+00:00"}
{"study_id": 76567, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the quality of evidence for physical therapy interventions, including neuromuscular electrical stimulation, in managing post-stroke spasticity.", "results_summary": "The study found moderate-quality evidence supporting the efficacy of neuromuscular electrical stimulation for post-stroke spasticity, suggesting it as a viable intervention among active strategies.", "population_specificity": "Adults over 18 years old with post-stroke spasticity.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:04.516599+00:00"}
{"study_id": 76569, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness of various rehabilitation techniques, including Neuromuscular Electrical Stimulation, for improving motor dysfunction after stroke.", "results_summary": "Neuromuscular Electrical Stimulation was found to be less effective than acupuncture therapy and virtual reality but more effective than mirror therapy and common therapy for improving lower limb balance function.", "population_specificity": "Poststroke patients with motor dysfunction (5128 patients across 74 randomized controlled trials).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:05.699434+00:00"}
{"study_id": 76568, "supplement_id": 1374, "safety_score": "95", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of prehabilitation with neuromuscular electrical stimulation (NMES) on muscle status and exercise capacity in patients before cardiac surgery.", "results_summary": "The study found that NMES significantly improved knee extensor strength, knee flexor strength, and six-minute walk test distance, with no complications reported during the intervention.", "population_specificity": "Preoperative elective cardiac surgery patients.", "effective_dosage": "7-10 sessions (specific frequency not detailed).", "study_duration": "Short-term (7-10 sessions).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:06.050353+00:00"}
{"study_id": 76572, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the effectiveness of neuromuscular electrical stimulation as a rehabilitation intervention for dysphagia in acute and subacute stroke patients.", "results_summary": "The study found that neuromuscular electrical stimulation was one of several interventions for dysphagia in stroke patients, with evidence quality ranging from very low to moderate. No specific efficacy data for neuromuscular electrical stimulation alone were highlighted.", "population_specificity": "Acute and subacute stroke patients with dysphagia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:09.099160+00:00"}
{"study_id": 76574, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to determine whether adding neuromuscular stimulation of the vastus medialis oblique (VMO) to Maitland's mobilization and exercises was more effective than Maitland's mobilization with exercises alone in treating knee osteoarthritis (OA).", "results_summary": "Both groups showed significant improvement in pain and disability, but the group receiving only Maitland's mobilization and exercises experienced greater relief compared to the group that also received neuromuscular stimulation.", "population_specificity": "Sixty patients with knee osteoarthritis.", "effective_dosage": "Not specified", "study_duration": "Eight weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:10.536135+00:00"}
{"study_id": 76570, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine whether a 2-week NMES or TENS intervention over the ankle pronators could improve neural excitability, performance, and patient-reported function in individuals with chronic ankle instability (CAI).", "results_summary": "TENS improved reflexive and cortical excitability in the short term, but these changes did not translate to significant improvements in clinical function, balance, or patient-reported outcomes. NMES showed no significant effects on any measured outcomes.", "population_specificity": "Twenty participants with chronic ankle instability (CAI).", "effective_dosage": "Sub-noxious NMES or sensory-level TENS applied over the ankle pronators during 5 sessions.", "study_duration": "2 weeks (with retention assessment at 4 weeks).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:10.734242+00:00"}
{"study_id": 76573, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of combining transcranial laser photobiomodulation with neuromuscular electrical stimulation (NMES) on cognitive and sensory-motor functions in post-stroke patients.", "results_summary": "The study found that NMES combined with transcranial laser improved cognitive function, pain relief, manual dexterity, and physical and social-emotional health, leading to better quality of life. Increased temperature was also observed in treated regions.", "population_specificity": "Post-stroke hemiplegic patients", "effective_dosage": "Symmetrical biphasic rectangular waveforms, 50 Hz frequency, 250 \u03bcs pulse duration, adjustable intensity (0\u2013150 mA)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:10.860324+00:00"}
{"study_id": 76571, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine if adding neuromuscular electrical stimulation core strength training (NMES) or progressive exercise (PEP) to primary care management (PCM) was more effective than PCM alone for improving disability, quality of life, and pain in service members with subacute low back pain.", "results_summary": "The study found that perceived disability, physical quality of life, and pain during activity improved in all groups, including NMES, over a 9-week intervention. Home therapies like NMES were helpful in reducing disability and pain in service members with subacute low back pain.", "population_specificity": "Service members with subacute low back pain.", "effective_dosage": "Not specified", "study_duration": "9 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:11.365999+00:00"}
{"study_id": 76575, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether combining neuromuscular electrical stimulation (NMES) with high protein supplementation and physical therapy could mitigate muscle loss and improve clinical outcomes in ICU patients compared to standard care.", "results_summary": "The NMES+HPRO+PT group showed less lower extremity muscle volume loss, larger thigh cross-sectional area, improved nitrogen balance, and reduced delirium compared to the standard care group, though no differences were observed in length of stay or mechanical ventilation days.", "population_specificity": "Mechanically ventilated ICU patients.", "effective_dosage": "30 minutes of NMES applied to quadriceps and dorsiflexors twice daily for 10 days, plus mean 1.3 \u00b1 0.4 g/kg body weight of high protein supplementation.", "study_duration": "14 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:14.570675+00:00"}
{"study_id": 76576, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of walking exercise with and without simultaneous hybrid training system (HTS) on liver stiffness and insulin resistance in NAFLD patients.", "results_summary": "The study found that walking exercise combined with HTS improved liver stiffness and insulin resistance compared to walking alone, as measured by transient elastography and homeostasis model assessment. Other metabolic markers like fasting blood glucose and liver enzymes were also evaluated.", "population_specificity": "32 subjects with nonalcoholic fatty liver disease (NAFLD) and BMI of 27 kg/m\u00b2.", "effective_dosage": "Triweekly 30-minute sessions of walking at 5.6 km/h with HTS.", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:14.812604+00:00"}
{"study_id": 76577, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of sensory neuromuscular electrical stimulation (SNMES) for treating oropharyngeal dysphagia, particularly in comparison to motor threshold stimulation and conventional therapy.", "results_summary": "Most studies showed significant improvement with SNMES, often comparable or superior to motor threshold stimulation and conventional therapy, though study designs and parameters varied widely without standardized guidelines. The suggested parameters include sensory threshold intensity, 80 Hz frequency, 700 \u03bcs impulse time, and 20 hours of stimulation over 2 weeks with submental electrode placement.", "population_specificity": "Older adults with oropharyngeal dysphagia following a cerebrovascular accident.", "effective_dosage": "Intensity at sensory threshold, frequency of 80 Hz, impulse time of 700 \u03bcs, total duration of 20 hours over 2 weeks.", "study_duration": "2 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:16.225382+00:00"}
{"study_id": 76578, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy of combined low and high-frequency NMES in improving both muscular strength and endurance in CKD patients undergoing hemodialysis.", "results_summary": "The study protocol outlines a rigorous evaluation of NMES effects on muscle function, body composition, exercise tolerance, and quality of life, but specific results are not yet reported as the trial is ongoing.", "population_specificity": "Patients with chronic kidney disease undergoing hemodialysis.", "effective_dosage": "Combined low and high frequencies, with intensity set to the highest tolerated by the patient (except for the sham group).", "study_duration": "24 sessions of follow-up.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:17.788138+00:00"}
{"study_id": 76581, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of neuromuscular electrical stimulation (NMES) combined with biofeedback-assisted pelvic floor muscle training (BAPFMT) on rectus diastasis closure and quality of life in postpartum women.", "results_summary": "The study found that NMES combined with BAPFMT significantly reduced inter-recti distance and improved physical quality of life scores compared to NMES alone. The results were statistically significant and clinically meaningful.", "population_specificity": "Postpartum women (2-6 months after delivery) with rectus diastasis, mean age 29.9 years.", "effective_dosage": "Not specified", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:20.227105+00:00"}
{"study_id": 76580, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effect of Neuromuscular Electrical Stimulation (NMES) on serum glucose levels in children and adolescents with type-1 diabetes.", "results_summary": "NMES significantly reduced fasting blood sugar (FBS) measured by glucometer and total daily insulin dose within 2 weeks of intervention. Laboratory FBS also decreased significantly post-intervention, though HbA1c reduction was not statistically significant.", "population_specificity": "Children and adolescents aged 7-18 years with type-1 diabetes mellitus.", "effective_dosage": "Two 20-minute NMES sessions on quadriceps and hamstrings muscles, three times per week.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:20.321729+00:00"}
{"study_id": 76582, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether neuromuscular electrical stimulation (NMES) combined with physiotherapy could prevent muscle wasting in ICU patients with sepsis/septic shock compared to physiotherapy alone.", "results_summary": "The study found no significant difference in muscle wasting between groups in the first week, but NMES + physiotherapy showed significantly less muscle loss in upper extremities on days 14 and 21 compared to physiotherapy alone. No significant difference was observed in anthropometric measurements.", "population_specificity": "ICU patients diagnosed with sepsis/septic shock.", "effective_dosage": "Not specified", "study_duration": "Measurements were taken on days 3, 7, 14, 21, and 28 after sepsis diagnosis.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:20.664745+00:00"}
{"study_id": 76583, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine if combining testosterone treatment with long pulse width stimulation (LPWS) could increase muscle size, leg lean mass, and improve metabolic health in individuals with spinal cord injury and muscle denervation.", "results_summary": "The study hypothesizes that 1-year TT+LPWS will upregulate protein synthesis, downregulate protein degradation, and enhance mitochondrial health, but results are pending as measurements are planned at baseline, 6 months, and post-intervention.", "population_specificity": "Male participants aged 18-70 with chronic spinal cord injury and denervation of both knee extensor muscles.", "effective_dosage": "Training sessions twice weekly (specific LPWS parameters not detailed).", "study_duration": "1 year", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:24.050901+00:00"}
{"study_id": 76585, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effectiveness and dosimetry of Neuromuscular Electrical Stimulation (NMES) with kiloHertz currents (kHz) on aspects of muscle function (AOMF) such as torque and hypertrophy in healthy individuals.", "results_summary": "The review found that kHz NMES can increase torque and generate hypertrophy, with Russian current studies specifically showing hypertrophy gains. However, dosimetry details were often lacking, making optimal parameter determination difficult.", "population_specificity": "Healthy people", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:24.496939+00:00"}
{"study_id": 76584, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether combining neuromuscular electrical stimulation (NMES) with isokinetic muscle strength (IMS) training improves muscle strength, flexibility, joint ROM, functional status, and quality of life in overweight/obese women with knee osteoarthritis.", "results_summary": "The study found that combining NMES with IMS significantly improved concentric strength at 240\u00b0/s, physical performance, muscle flexibility, and quality of life compared to standard rehabilitation. However, no significant improvements were observed in muscle strength at 60\u00b0/s, force asymmetry, or joint ROM.", "population_specificity": "Overweight/obese women with knee osteoarthritis.", "effective_dosage": "Two sessions per week (specific NMES parameters not detailed).", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:24.972084+00:00"}
{"study_id": 76579, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of non-invasive foot NMES on lower leg symptoms in an elderly, ambulant, and otherwise healthy population.", "results_summary": "The abstract does not provide specific results regarding the effects of NMES, as it appears to describe the study design rather than outcomes.", "population_specificity": "Elderly, ambulant, and otherwise apparently healthy individuals with lower leg symptoms (aches, pain, cramps).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:26.693004+00:00"}
{"study_id": 76586, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness of sensory and motor-level neuromuscular electrical stimulation (NMES) in treating post-stroke dysphagia.", "results_summary": "Sensory-level NMES showed significant improvement in swallow function (FAM, DOSS, NOMS), while motor-level NMES did not. Combined NMES groups improved significantly on most measures, but no significant difference was found between sensory and motor groups.", "population_specificity": "Thirty-one stroke survivors with dysphagia within 6 months of stroke onset, excluding those with contraindications for electrical stimulation or pre-existing conditions.", "effective_dosage": "45 minutes per session, 10 sessions total (sensory or motor intensity).", "study_duration": "10 sessions (duration per session: 45 minutes).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:28.512846+00:00"}
{"study_id": 76588, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare changes in functional connectivity within a cortical network induced by contralaterally controlled neuromuscular electrical stimulation (CCNMES) versus traditional neuromuscular electrical stimulation (NMES) during wrist extension in stroke patients.", "results_summary": "The study found that CCNMES was associated with distinct changes in functional connectivity compared to NMES, suggesting potential differences in cortical activation patterns between the two therapies. However, the abstract does not specify the magnitude or clinical significance of these differences.", "population_specificity": "Thirty-one stroke patients with right hemisphere lesions.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:28.858144+00:00"}
{"study_id": 76587, "supplement_id": 1374, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the hemodynamic effects of TENS, NMES, and sham stimulation on venous flow in healthy young individuals.", "results_summary": "NMES significantly increased flow volume and peak velocity in the popliteal vein, though less than TENS. NMES was less tolerated than TENS but without statistically significant discomfort differences.", "population_specificity": "24 healthy university students (50% male).", "effective_dosage": "Not specified (5 Hz-TENS and NMES applied to soleus muscle).", "study_duration": "Not specified (single session per stimulation type).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:29.781750+00:00"}
{"study_id": 76591, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of resistance exercise alone versus resistance exercise combined with neuromuscular electrical stimulation (NMES) on muscle strength and mobility in hematological cancer patients undergoing chemotherapy.", "results_summary": "The study found that resistance exercise improved muscle weakness in hematological cancer patients, and combining NMES with resistance exercise yielded comparable significant results to resistance exercise alone in patients with moderate-low ECOG-PS.", "population_specificity": "Adult hematological cancer patients receiving intensive chemotherapy after hematopoietic stem cell transplantation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:32.736574+00:00"}
{"study_id": 76589, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of exercise training plus neuromuscular electrical stimulation versus exercise training alone on shoulder function, pain, range of motion, and muscle strength in patients with subacromial impingement syndrome.", "results_summary": "The study found that adding neuromuscular electrical stimulation to exercise training did not improve shoulder function (primary outcome) more than exercise alone but did enhance muscle strength, external-rotation range of motion, and reduced pain during activity and at night (secondary outcomes). Effect sizes were medium to large for both groups.", "population_specificity": "Patients with subacromial impingement syndrome (n=48, divided into two groups of 24 each).", "effective_dosage": "Not specified", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:33.040057+00:00"}
{"study_id": 76592, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of combining NMES of the calf and quadriceps on individuals with knee osteoarthritis (KOA) to manage symptoms.", "results_summary": "The study is ongoing, so no results are reported in the abstract. The primary outcome will be the Western Ontario and McMaster Universities Arthritis Index pain domain at 8 weeks, with secondary outcomes including muscle strength, quality of life, and other measures.", "population_specificity": "193 individuals with knee osteoarthritis.", "effective_dosage": "Footplate stimulation daily for 30 min and quadriceps stimulation for 20 min, five times a week.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:33.919074+00:00"}
{"study_id": 76590, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the long-term efficacy of mobile app-based neuromuscular electrical stimulation (NMES) in reducing pain for patients with knee osteoarthritis over an additional 14-week period following a 12-week trial.", "results_summary": "In the per-protocol compliant population, active NMES showed significantly greater pain reduction (64.7% vs. 24.3%) and higher rates of \u226550% pain improvement (76.2% vs. 12.5%) compared to sham NMES. No marked differences were observed in the intent-to-treat population.", "population_specificity": "Patients with knee osteoarthritis who completed a prior 12-week NMES trial.", "effective_dosage": "Two 20-minute daily sessions, 5 days per week.", "study_duration": "14 weeks (extension study; total 26 weeks including parent study).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:34.189872+00:00"}
{"study_id": 76593, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of traditional dysphagia therapy (TDT) alone versus TDT combined with neuromuscular electrical stimulation (NMES) on swallowing functionality and related outcomes in post-stroke dysphagia patients.", "results_summary": "Both groups showed significant post-intervention improvements, but the NMES group demonstrated additional benefits in reducing leakage and penetration-aspiration levels with semi-solid food. Improvements were maintained at the 3-month follow-up.", "population_specificity": "Thirty-four patients with post-stroke dysphagia (PSD).", "effective_dosage": "Sensory NMES was applied for 45 minutes per session, 5 days a week for 3 weeks.", "study_duration": "3 weeks of intervention, with follow-up at 3 months post-intervention.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:36.191647+00:00"}
{"study_id": 76594, "supplement_id": 1374, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness and safety of NMES in preventing muscle atrophy in ICU patients without nerve injury, specifically evaluating different muscle stimulation approaches.", "results_summary": "NMES combined with early exercise training reduced muscle atrophy in ICU patients, with simultaneous agonist/antagonist muscle stimulation (Exp I) showing better results than single-muscle stimulation (Exp II). No significant differences were observed in prothrombin time, lactic acid, or C-reactive protein levels across groups.", "population_specificity": "ICU patients without central or peripheral nerve injury.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:37.233673+00:00"}
{"study_id": 76596, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of neuromuscular electrical stimulation (NMES) on exercise capacity, dyspnea, quality of life, and physical activity in people with COPD.", "results_summary": "The study found it uncertain whether NMES has an effect on exercise capacity, dyspnea, quality of life, and physical activity in COPD patients, based on the analyzed systematic reviews.", "population_specificity": "People with chronic obstructive pulmonary disease (COPD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:37.300232+00:00"}
{"study_id": 76595, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effect of long-duration neuromuscular electrical stimulation (NMES) on shoulder subluxation and upper-extremity function in acute post-stroke patients.", "results_summary": "NMES significantly reduced shoulder subluxation and improved upper-extremity function (FMA-UE, FMA-hand and finger subscales) compared to sham treatment, with benefits sustained at follow-up. Functional Independence Measure (FIM) also improved more in the NMES group, but no change in pain levels was observed in either group.", "population_specificity": "Acute post-stroke patients (mean age 70.0 \u00b1 14.0 years).", "effective_dosage": "NMES applied to supraspinatus and posterior deltoid muscles (specific parameters not detailed).", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:38.726825+00:00"}
{"study_id": 76598, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of chronic NMES+ training on muscle strength and mass compared to conventional volitional training or passive electrical stimulation alone.", "results_summary": "The majority of studies reported increased muscle strength with NMES+, particularly when superimposed on sub-maximal exercises involving concentric and eccentric contractions. Muscle mass results were mixed, with two studies showing increases and two showing no differences.", "population_specificity": "Healthy participants or orthopedic patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:40.655208+00:00"}
{"study_id": 76600, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether combining neuromuscular electrical stimulation (NMES) with plyometric and strength training enhances muscular, sprint, and functional performances in collegiate male football players compared to sham NMES.", "results_summary": "The study found that both NMES and sham NMES combined with plyometric and strength training improved performance, but NMES showed a greater advantage in enhancing muscular and sprint performance among the participants.", "population_specificity": "Collegiate male football players (n=60).", "effective_dosage": "Not specified.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:42.329967+00:00"}
{"study_id": 76597, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate recent studies on the effectiveness of transcutaneous NMES applied to the anterior neck as a treatment for dysphagia, considering variations in stimulation protocols, electrode placement, and patient conditions.", "results_summary": "The review identified 18 studies, with 16 reporting beneficial outcomes for NMES, particularly when combined with traditional dysphagia therapy (TDT) in stroke, Parkinson's disease, and brain injury patients. However, further research is needed to determine optimal protocols and settings for different patient groups and impairment levels.", "population_specificity": "Patients with dysphagia, including post-stroke, Parkinson's disease, and brain injury cases.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:42.395274+00:00"}
{"study_id": 76599, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether NMES of the deltoid could lead to early restoration of shoulder function after reverse total shoulder arthroplasty (RSA).", "results_summary": "NMES contributed to significantly faster restoration of range of motion (ROM) and improvement in external rotation power at 3 and 6 months postoperatively, but no significant differences were found in pain scores (VAS), ASES, or Constant scores, or in deltoid thickness measurements.", "population_specificity": "88 patients who underwent RSA for cuff tear arthropathy or irreparable rotator cuff tear.", "effective_dosage": "NMES was applied to the middle and posterior deltoid area, maintained for 1 month postoperatively (specific frequency not detailed).", "study_duration": "1 month", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:43.265147+00:00"}
{"study_id": 76601, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of two NMES protocols on multifidus muscle morphology and function in individuals with non-specific chronic low back pain (CLBP) and assess their impact on pain and disability.", "results_summary": "The abstract does not provide results, as the study appears to be ongoing or not yet completed.", "population_specificity": "30 participants aged 18-60 with non-specific CLBP, recruited from local orthopedic clinics and databases.", "effective_dosage": "20 supervised electrotherapy treatments over 10 weeks (frequency not specified).", "study_duration": "10 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:44.790066+00:00"}
{"study_id": 76604, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess the effects of neuromuscular electrical stimulation on upper limb function, muscle strength, and spasticity in children with cerebral palsy.", "results_summary": "Neuromuscular electrical stimulation combined with other therapies significantly improved functional scale scores, muscle strength, and spasticity in the upper limbs but did not enhance wrist range of motion. The functional benefits persisted at a 3-month follow-up.", "population_specificity": "Children with cerebral palsy", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:46.523732+00:00"}
{"study_id": 76603, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy of high-frequency rTMS and TNES in improving dysphagia in acute post-stroke patients.", "results_summary": "TNES significantly improved swallowing disturbance (SDQ), pharyngeal residue (YPRSRS), and penetration/aspiration severity (PAS) compared to controls, though rTMS was more effective for SDQ and PAS. Both interventions showed comparable efficacy for YPRSRS.", "population_specificity": "Right-handed acute ischemic stroke patients with post-stroke dysphagia (mean age 60.53 \u00b1 8.23 years).", "effective_dosage": "Not specified", "study_duration": "Intervention administered between the 2nd and 10th days post-stroke.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:47.735074+00:00"}
{"study_id": 76605, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "To determine whether neuromuscular electrical stimulation of calf muscles could improve nocturnal symptoms and quality of life in asthmatic children.", "results_summary": "Neuromuscular electrical stimulation significantly improved nocturnal symptoms, quality of life, and other measured variables compared to breathing exercises alone, with results comparable to aerobic exercise. The intervention showed statistically significant benefits over the control group in all outcomes.", "population_specificity": "60 children (8-12 years) with moderate asthma.", "effective_dosage": "Five days a week for 30 minutes, alongside supervised breathing exercises.", "study_duration": "12 consecutive weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:49.017911+00:00"}
{"study_id": 76607, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy of contralaterally controlled functional electrical stimulation (CCFES) with neuromuscular electrical stimulation (NMES) in improving upper extremity motor recovery after stroke.", "results_summary": "CCFES showed greater improvements than NMES in upper extremity function (measured by UEFMA, BBT, AROM, and mBI), but no significant difference was found for AMAT. The meta-analysis included six RCTs with 267 participants.", "population_specificity": "People with upper extremity hemiplegia after stroke.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:50.533372+00:00"}
{"study_id": 76606, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether a new neuromuscular electrical stimulation system (Helping Hand) could improve motor, sensory, and body representation recovery in chronic stroke patients compared to conventional treatment and a robotic glove.", "results_summary": "The Helping Hand (HH) system provided earlier motor benefits than the robotic glove (GR) and showed higher overall improvement in motor and somatosensory functions, which persisted at follow-up. HH also improved perceived limb dimensions and reduced altered feelings toward the affected limb, with benefits correlating with motor improvements and dependent on HH dosage.", "population_specificity": "Sixty chronic stroke patients with unilateral motor deficits.", "effective_dosage": "Not specified (groups received dose-matched interventions, with GRHH receiving 50% GR and 50% HH).", "study_duration": "9 weeks of treatment, with follow-up at week 13.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:52.660301+00:00"}
{"study_id": 76609, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to confirm the efficacy of contralaterally controlled functional electrical stimulation (CCFES) for post-stroke upper limb rehabilitation compared to cyclic neuromuscular electrical stimulation (cNMES) and task-oriented training (TOT).", "results_summary": "The study builds on prior pilot and single-site studies showing positive effects of CCFES on upper limb impairment and hand dexterity in stroke survivors, but results from this multi-site trial are pending. The primary endpoint is change in dexterity from baseline to 6 months post-treatment.", "population_specificity": "Stroke survivors with moderate to severe upper extremity hemiparesis.", "effective_dosage": "Not specified", "study_duration": "12 weeks of therapy", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:53.705820+00:00"}
{"study_id": 76608, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether combining repetitive facilitative exercise (RFE) with neuromuscular electrical stimulation (NMES) improves upper limb function in stroke patients with severe paresis.", "results_summary": "The study found that the combination of RFE and NMES significantly improved Fugl-Meyer Assessment scores for wrist and finger function compared to conventional training alone, suggesting enhanced distal limb recovery in severe stroke patients.", "population_specificity": "Stroke patients with very severe upper limb paresis (Finger-Function test scores of zero or 1a on the Stroke Impairment Assessment Set).", "effective_dosage": "20 minutes of group-specific training (NMES, RFE, RFE under NMES, or conventional training) plus 40 minutes of conventional exercise daily.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:55.104242+00:00"}
{"study_id": 76610, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare intervention modalities, including Neuromuscular Electrical Stimulation (NMES), for increasing skeletal muscle mass in paralyzed limbs of individuals with chronic, motor complete spinal cord injury.", "results_summary": "NMES-based resistance training on the quadriceps produced the largest and most consistent increases in skeletal muscle mass among all interventions reviewed. However, the overall studies demonstrated a high risk of bias, and more high-quality trials are needed to optimize training variables.", "population_specificity": "Adults (>18 years) with chronic (>1-year post-injury), motor complete spinal cord injury.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:55.538971+00:00"}
{"study_id": 76602, "supplement_id": 1374, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "To determine whether neuromuscular electrical stimulation (NMES) improves mobility in children with spastic cerebral palsy.", "results_summary": "NMES improved walking speed and the standing, walking, running, and jumping dimension of the Gross Motor Function Measure compared to conventional physical therapy. The study concluded that NMES is safe and effective for improving mobility in this population.", "population_specificity": "Children with spastic cerebral palsy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:55.661545+00:00"}
{"study_id": 76611, "supplement_id": 1374, "safety_score": "80", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to determine whether simultaneous NMES on quadriceps and gluteal muscles (QG) compared to quadriceps alone (Q) affects knee extensor force production and discomfort.", "results_summary": "The study found no significant difference in knee extensor force production or discomfort between QG-NMES and Q-NMES, with both methods producing comparable results at maximum tolerated intensity and 20% of MVC.", "population_specificity": "11 healthy participants (6 females), aged 19-54 years, with normal weight.", "effective_dosage": "NMES-intensity increased stepwise until maximal tolerable level was reached; specific mA values not provided.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:57.488367+00:00"}
{"study_id": 76612, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate whether adding early neuromuscular electrical stimulation (NMES) to an early mobilization (EM) protocol improves functional outcomes in mechanically ventilated ICU patients.", "results_summary": "The EM+NMES group showed significantly better functional status scores, shorter hospital stays, fewer days to stand up, lower ICU-acquired weakness, and improved muscle strength compared to the EM-only group.", "population_specificity": "Mechanically ventilated patients within the first 48 hours of ICU admission.", "effective_dosage": "NMES was administered for 60 minutes, 5 days a week.", "study_duration": "From the first 48 hours of ICU admission until ICU discharge.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:58.554161+00:00"}
{"study_id": 76613, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to summarize the role of sEMG assessments, including Neuromuscular Electrical Stimulation (NMES), in neurorehabilitation after spinal cord injury (SCI) and evaluate its clinical relevance.", "results_summary": "The review found that NMES was among the interventions studied using sEMG to assess muscle activation and rehabilitation effects, but it highlighted the need for further research on long-term reliability and physiological interpretation of sEMG data.", "population_specificity": "Individuals with spinal cord injury (SCI) undergoing neurorehabilitation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:58.986134+00:00"}
{"study_id": 76614, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to determine the effectiveness of Neuromuscular Electrical Stimulation (NMES) for treating oropharyngeal dysphagia in children.", "results_summary": "Swallowing function improved after NMES treatment in all included studies, with some evidence of improved feeding ability, though the studies had moderate to high risk of bias and short follow-up durations.", "population_specificity": "Children aged \u226418 years with oropharyngeal dysphagia, including those with neurologic impairments (mean/median age below 7 years).", "effective_dosage": "Not specified", "study_duration": "Follow-up was less than 6 months in most studies.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:51:02.466462+00:00"}
{"study_id": 76615, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether a hybrid training system (HTS) providing antagonist muscle electrical stimulation was more effective than sensory TENS in altering pain sensitivity in women with obesity and frequent knee symptoms during walking exercise.", "results_summary": "The HTS group showed statistically significant improvement in local pain sensitivity at the knee compared to the control group, but no significant difference was found for remote pain sensitivity at the wrist. The HTS group also demonstrated a trend toward reduced knee pain, though this did not reach statistical significance.", "population_specificity": "Women aged 40-70 with obesity and daily knee symptoms (N=28).", "effective_dosage": "Biweekly 30-minute walking sessions with HTS or sensory TENS.", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:51:03.456702+00:00"}
{"study_id": 76617, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the latest evidence for behavioral swallowing therapies, including Neuromuscular Electrical Stimulation, for Parkinson's disease-related dysphagia to inform evidence-based treatment decisions.", "results_summary": "Behavioral therapies, including those enhancing airway function and intensive targeted swallowing treatment, improved swallowing function in PD, but the chin-down strategy showed no significant effect. EMST detraining effects suggested a need for maintenance training.", "population_specificity": "Patients with Parkinson's disease (PD) experiencing dysphagia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:51:04.147581+00:00"}
{"study_id": 76616, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the clinical effects of neuromuscular electrical stimulation (NMES) in preventing deep venous thrombosis (DVT) of the lower extremities after anterior cruciate ligament reconstruction.", "results_summary": "The study found no significant differences in baseline characteristics between the experimental (NMES) and control groups. Outcomes such as VAS score, blood D-dimer levels, knee circumference, and DVT screening results were compared pre- and post-operation.", "population_specificity": "187 males and 91 females who underwent anterior cruciate ligament reconstruction.", "effective_dosage": "Not specified", "study_duration": "Intervention was administered from pre-operation to the fourth day post-operation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:51:04.808049+00:00"}
{"study_id": 76618, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to determine if adding NMES to TKA rehabilitation improves quadriceps strength recovery compared to standardized rehabilitation and to identify common NMES pulse settings and their effectiveness.", "results_summary": "NMES was found to be effective for quadriceps strength recovery, particularly early after TKA, with similar long-term effects to traditional strength training. Short duration and low-intensity NMES had limited effects, and there was heterogeneity in NMES methodologies and pulse settings.", "population_specificity": "Patients undergoing total knee arthroplasty (TKA).", "effective_dosage": "Not specified (heterogeneity in NMES settings noted).", "study_duration": "Not specified (varied across studies).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:51:05.185241+00:00"}
{"study_id": 76619, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to determine whether neuromuscular electrical stimulation (NMES) improves lower limb muscle strength after living donor liver transplant (LDLT).", "results_summary": "The study found no significant difference in muscle strength, functional capacity, activities of daily living, or hospital stay between the NMES and control groups after 4 weeks. However, the authors suggested further research with novel NMES devices or other body areas might yield different results.", "population_specificity": "Adult patients who underwent living donor liver transplant (LDLT) at a university hospital.", "effective_dosage": "NMES applied to quadriceps muscles starting 1 day post-LDLT (frequency not specified).", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:51:06.893602+00:00"}
{"study_id": 76620, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 50, "study_goal": "The researchers aimed to explore the potential effectiveness of Neuromuscular Electrical Stimulation as a rehabilitation procedure for managing sarcopenic dysphagia.", "results_summary": "The abstract suggests that Neuromuscular Electrical Stimulation is one of several possible rehabilitation procedures for sarcopenic dysphagia, but its specific efficacy remains unclear due to the narrative review's broad scope and lack of detailed findings.", "population_specificity": "Patients with sarcopenic dysphagia (dysphagia with generalized sarcopenia).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:51:07.524413+00:00"}
{"study_id": 76622, "supplement_id": 1374, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Neuromuscular Electrical Stimulation (NMES) is metabolically safe when administered within the first 72 hours of septic shock diagnosis or later.", "results_summary": "The study found no significant differences in metabolic variables (e.g., Oxygen Consumption) during NMES compared to control protocols, indicating NMES is metabolically safe in both acute and late phases of septic shock. However, metabolic demand was higher in the acute phase.", "population_specificity": "Patients with acute septic shock (within 72 hours of diagnosis) and late-phase sepsis/septic shock (after 72 hours).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Intervention and control protocols were compared with a wash-out period of 4 to 6 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:51:09.111417+00:00"}
{"study_id": 76623, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether preoperative neuromuscular electrical stimulation (NMES) improves postoperative quadriceps muscle strength, functional status, and quality of life in patients undergoing fast-track total knee arthroplasty (TKA).", "results_summary": "Preoperative NMES showed significant improvement in patient-reported function (KOOS-function in daily living and WOMAC total score) but had non-significant trends for quadriceps strength, pain, symptoms, performance-based activity, and quality of life. No significant postoperative benefits were observed between groups.", "population_specificity": "Patients scheduled for fast-track total knee arthroplasty (TKA).", "effective_dosage": "20 minutes per session, 5 times daily.", "study_duration": "6 weeks before surgery.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:51:12.142190+00:00"}
{"study_id": 76626, "supplement_id": 1374, "safety_score": "90", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the safety and effectiveness of inspiratory plus expiratory neuromuscular electrical stimulation in subjects with severe COPD.", "results_summary": "The study found that inspiratory plus expiratory neuromuscular electrical stimulation significantly improved functional exercise capacity (6MWD) in severe COPD patients compared to diaphragm pacing, with no serious adverse events reported. Secondary outcomes showed no significant differences between groups, except for improvements in FEV1 and FEV1/FVC in GOLD-4 COPD subjects.", "population_specificity": "Stable COPD patients with severe respiratory impairment.", "effective_dosage": "Not specified", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:51:12.767701+00:00"}
{"study_id": 76625, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness and cost-effectiveness of conventional pelvic floor muscle training (PFMT) versus biofeedback-mediated PFMT combined with neuromuscular electrical stimulation (NMES) for improving pelvic organ prolapse (POP) symptoms in postpartum women.", "results_summary": "The study found that biofeedback-mediated PFMT combined with NMES was evaluated for its long-term efficacy in improving POP-Q staging and quality of life, with results pending at 36 months post-intervention. The trial design suggests potential benefits, but conclusive outcomes are not yet reported.", "population_specificity": "Postpartum women with symptomatic pelvic organ prolapse (POP).", "effective_dosage": "Not specified", "study_duration": "12 weeks (with follow-up until 36 months)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:51:13.301166+00:00"}
{"study_id": 76627, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to assess the benefits and harms of foot orthoses (FOs) for treating paediatric flat feet, including interventions like neuromuscular electrical stimulation (NMES).", "results_summary": "The abstract does not provide specific results for NMES, as the focus was primarily on comparing foot orthoses (CFOs, PFOs) versus shoes and each other. NMES was listed as one of the interventions but not analyzed separately.", "population_specificity": "Children aged 11 months to 19 years with flexible flat feet, including asymptomatic, juvenile idiopathic arthritis (JIA), symptomatic, and developmental co-ordination disorder (DCD) presentations.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:51:14.702290+00:00"}
{"study_id": 76624, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the immediate effects of a single NMES session on foot force production, foot dome stability, and dynamic postural control in individuals with static foot pronation.", "results_summary": "A single NMES session significantly improved foot function and dynamic postural control compared to sham stimulation, with 78% of NMES participants responding positively to at least two outcomes. The relative risk of being a responder was 3.6 times higher in the NMES group.", "population_specificity": "46 participants (23 males, 23 females) with static foot pronation (Foot Posture Index score \u2265 6).", "effective_dosage": "15-minute NMES session on the dominant foot.", "study_duration": "Single 15-minute session.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:51:14.778252+00:00"}
{"study_id": 76629, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of neuromuscular electrical stimulation (NMES) and other activity-based physical therapies in influencing bone metabolism and increasing bone mineral density (BMD) in individuals with spinal cord injury (SCI).", "results_summary": "The study found sparse and inconsistent evidence supporting NMES and other physical rehabilitation regimens in improving bone metabolism or BMD at fracture-prone sites in individuals with severe SCI. The review highlights the need for optimized ABPT approaches for bone recovery post-SCI.", "population_specificity": "Individuals with spinal cord injury (SCI), particularly those with severe paralysis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:51:16.862329+00:00"}
{"study_id": 76628, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the therapeutic effects of NMES with pulse widths of 300 \u03bcs and 200 \u03bcs for treating overactive bladder (OAB) in elderly women.", "results_summary": "NMES significantly reduced OAB symptom scores in both groups, with greater improvement observed in the 300 \u03bcs group. Both pulse widths increased myoelectric potential in Type I and Type II muscle fibers, but the 300 \u03bcs group showed significantly higher improvements.", "population_specificity": "Postmenopausal elderly women without pelvic organ prolapse (POP).", "effective_dosage": "Group A: 300 \u03bcs pulse width; Group B: 200 \u03bcs pulse width.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:51:17.706304+00:00"}
{"study_id": 76630, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to assess the benefits and harms of foot orthoses (FOs) for treating paediatric flat feet, including interventions like neuromuscular electrical stimulation (NMES).", "results_summary": "The abstract does not provide specific results for NMES, as the focus was primarily on comparing foot orthoses (CFOs, PFOs) versus shoes and each other. NMES was listed as one of the interventions but not analyzed separately.", "population_specificity": "Children aged 11 months to 19 years with flexible flat feet, including asymptomatic, juvenile idiopathic arthritis (JIA), symptomatic, and developmental co-ordination disorder (DCD) presentations.", "effective_dosage": "Not specified", "study_duration": "Not specified for NMES", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:51:18.669422+00:00"}
{"study_id": 76631, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "To investigate the effect of NMES combined with rTMS on upper limb motor dysfunction in stroke patients with hemiplegia.", "results_summary": "NMES combined with rTMS significantly improved upper extremity motor function and daily life activities in stroke patients with hemiplegia, outperforming NMES or rTMS alone. The combined treatment group showed notably higher scores in FMA-UE, MBI, and MAS compared to other groups.", "population_specificity": "240 stroke patients with hemiplegia", "effective_dosage": "Not specified", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:51:20.280284+00:00"}
{"study_id": 76633, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of neuromuscular electrical stimulation on functional capacity in patients during the immediate postoperative period of cardiac surgery.", "results_summary": "The study found no significant difference in the distance walked (primary outcome) or other functional measures between the intervention and control groups, concluding that neuromuscular electrical stimulation provided no benefit in this context.", "population_specificity": "Patients in the immediate postoperative period of cardiac surgery at a specialist hospital in Brazil.", "effective_dosage": "60 minutes per session, twice a day, for up to 10 sessions.", "study_duration": "Up to 5 days post-surgery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:51:21.583088+00:00"}
{"study_id": 76632, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "To compare the effectiveness of contralaterally controlled functional electrical stimulation (CCFES) versus neuromuscular electrical stimulation (NMES) on motor recovery of the upper limb in subacute stroke patients.", "results_summary": "Both CCFES and NMES improved upper limb motor function, but CCFES did not show a superior treatment effect compared to NMES. CCFES significantly enhanced the sEMG response of the paretic extensor carpi radialis but did not reduce antagonist cocontraction.", "population_specificity": "Subacute stroke patients within six months poststroke.", "effective_dosage": "Not specified", "study_duration": "3 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:51:21.718521+00:00"}
{"study_id": 76635, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers sought to determine whether Neuromuscular Electrical Stimulation (NMES) improves functional strength and endurance in addition to muscle hypertrophy.", "results_summary": "NMES treatment led to statistically significant improvements in abdominal and quadriceps strength and endurance, with nonsignificant changes in waist and quadriceps circumference. High subject satisfaction was reported for strength improvements.", "population_specificity": "26 subjects randomized into 3 groups (2 treatment, 1 control).", "effective_dosage": "4 NMES treatments over 2 weeks.", "study_duration": "2 weeks of intervention, with follow-up at 4 and 8 weeks posttreatment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:51:23.190821+00:00"}
{"study_id": 76634, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to investigate the cardiovascular safety, applicability, and effects of blood flow restriction combined with passive mobilization (BFRp) or neuromuscular electrical stimulation (BFRpE) on neuromuscular adaptations, physical function, and quality of life in comatose ICU patients.", "results_summary": "The study protocol was designed to evaluate the effects of BFRp and BFRpE, but results were not yet available as the abstract describes a prospective trial. The discussion suggests the data will inform future trials on preventing muscle atrophy and improving physical function and quality of life.", "population_specificity": "Comatose patients in intensive care units (ICUs).", "effective_dosage": "Training protocol applied to both legs alternately, twice a day with a 4-hour interval.", "study_duration": "Until coma awakening, death, or ICU discharge.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:51:24.889131+00:00"}
{"study_id": 76636, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the differential effectiveness of intradialytic neuromuscular electrical stimulation (NMES) and protein supplementation on muscle strength, mass, physical function, and quality of life in hemodialysis patients.", "results_summary": "The study found that intradialytic NMES improved muscular strength, mass, functional capacity, and quality of life in hemodialysis patients, with potential synergistic effects when combined with protein supplementation.", "population_specificity": "Hemodialysis patients with sarcopenia.", "effective_dosage": "NMES delivered to four areas of the bilateral vastus medialis and vastus lateralis using a 4-channel NMES instrument; 25 g of protein supplements provided per dialysis session.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:51:26.114068+00:00"}
{"study_id": 76638, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of intravaginal NMES combined with PFMT on urinary loss and quality of life in women with SUI, as well as its cost-effectiveness and cost-utility.", "results_summary": "The study protocol suggests that NMES combined with PFMT may be an effective treatment option for SUI, but specific results are not detailed in the abstract. The hypothesis is that concurrent NMES and PFMT will optimize treatment outcomes.", "population_specificity": "Women (biological) aged \u226518 years with stress urinary incontinence (\u22651 episode/week), excluding those with vaginal/urinary infections, virginity, pregnancy/puerperium, or neurological diseases.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:51:27.895355+00:00"}
{"study_id": 76637, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to systematically map rehabilitative interventions, including Neuromuscular Electrical Stimulation (PES), for dysphagia in patients with moderate-to-severe acquired brain injury (ABI).", "results_summary": "The study found positive tendencies towards beneficial effects for PES (a form of Neuromuscular Electrical Stimulation) in retraining swallowing function in ABI patients, though it emphasized the need for standardized protocols and outcome measures.", "population_specificity": "Patients with moderate-to-severe ABI (predominantly stroke) and dysphagia in the acute and subacute phase (within 6 months of injury).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:51:28.165614+00:00"}
{"study_id": 76641, "supplement_id": 1374, "safety_score": "80", "efficacy_score": 20, "quality_score": 65, "study_goal": "The researchers aimed to assess the effects of short-term intradialytic NMES on inflammation and quality of life in chronic kidney disease patients undergoing hemodialysis.", "results_summary": "The study found no significant changes in cytokine concentrations (hs-CRP, IL-6, IL-10, TNF\u03b1) or quality of life domains after NMES intervention. Muscle strength and mass also showed no differences between groups.", "population_specificity": "Adult hemodialysis patients with chronic kidney disease (control group: n=11, NMES group: n=10).", "effective_dosage": "NMES applied bilaterally at thigh and calves for 40 minutes during each hemodialysis session (three times a week).", "study_duration": "1 month", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:51:30.416619+00:00"}
{"study_id": 76643, "supplement_id": 1374, "safety_score": "80", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to determine the effects of Neuromuscular Electrical Stimulation (NMES) on functional capacity and quality of life in cardiac surgery patients.", "results_summary": "NMES improved knee extensor strength but had no significant effects on 6-minute walking distance, walking speed, grip strength, or quality of life. The evidence was limited by low to moderate study quality.", "population_specificity": "Cardiac surgery patients (400 participants across six studies).", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:51:30.764250+00:00"}
{"study_id": 76642, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "To determine the effects of NMES/FES training on body composition parameters (e.g., muscle cross-sectional area, lean mass, fat mass) in individuals with spinal cord injury.", "results_summary": "NMES/FES training increased muscle cross-sectional area by an average of 26% and showed modest changes in lean mass and fat mass. Higher weekly training volumes correlated with greater muscle hypertrophy.", "population_specificity": "Individuals with spinal cord injury.", "effective_dosage": "Stimulation parameters ranged from 200-1000 \u03bcs pulse duration, 2-60 Hz frequency, and 10-200 mA amplitude.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:51:31.256454+00:00"}
{"study_id": 76644, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the effectiveness of non-invasive neurostimulation therapies, including Neuromuscular Electrical Stimulation (sNMES), in improving swallowing function in dysphagia patients after stroke.", "results_summary": "The meta-analysis found that non-invasive neurostimulation therapies, including sNMES, significantly improved swallowing function in stroke patients compared to controls, with rTMS showing the best performance in subgroup analyses. The effect was more pronounced in acute-phase patients and those with brainstem injuries.", "population_specificity": "Stroke patients with dysphagia (914 participants across 27 RCTs).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:51:33.851718+00:00"}
{"study_id": 76640, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of NMES on muscle torque and sports performance in long-distance recreational runners.", "results_summary": "The NMES group showed significant improvements in peak isometric, concentric, and eccentric quadriceps muscle torque, as well as enhanced ventilatory anaerobic thresholds and oxygen cost of transport compared to controls.", "population_specificity": "Long-distance recreational runners (30 volunteers, 15 in each group).", "effective_dosage": "1 kHz, modulated in 2 ms bursts, 50 Hz modulated burst frequency, 10% duty cycle, 15 min per session (18 contractions per session), 3 sessions per week.", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:51:33.872548+00:00"}
{"study_id": 76647, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to investigate the molecular pathways and potential interventions, including physical rehabilitation and drug combinations, to mitigate muscle atrophy following severe spinal cord injury.", "results_summary": "The study identified rapid muscle atrophy post-SCI driven by specific signaling cascades and highlighted the limited effectiveness of traditional anabolic agents, suggesting combined physical rehabilitation and targeted drug therapies as a more promising approach.", "population_specificity": "Individuals with severe spinal cord injury (SCI).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:51:36.438178+00:00"}
{"study_id": 76646, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness of neuromuscular electrical stimulation (NMES) training and a progressive exercise program (PEP) versus standard primary care management (PCM) in improving physical performance, pain, and torso strength in service members with subacute low back pain.", "results_summary": "NMES showed greater improvement than PCM in physical performance (sit-ups and push-ups) and similar improvements in torso strength, with no group differences in pain levels. NMES muscle stimulation amount directly correlated with improvement, unlike PEP exercise hours.", "population_specificity": "Active duty military personnel (n=128) with subacute low back pain at Fort Campbell, Kentucky.", "effective_dosage": "Not specified", "study_duration": "9 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:51:38.700944+00:00"}
{"study_id": 76645, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to investigate NMES as an adjunctive pre- and post-operative treatment for rectal cancer patients undergoing radical pelvic surgery to assess its efficacy in improving key health outcomes.", "results_summary": "The study is a phase II randomized controlled trial evaluating NMES's impact on skeletal muscle attenuation (a marker of myosteatosis), sarcopenia, quality of life, inflammatory status, and cancer-specific outcomes, but results are not yet reported.", "population_specificity": "Rectal cancer patients undergoing radical pelvic surgery (pelvic exenteration).", "effective_dosage": "Not specified", "study_duration": "2 weeks pre-operatively and 8 weeks post-operatively (total 10 weeks).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:51:38.737562+00:00"}
{"study_id": 76648, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to compare the effectiveness of laparoscopic implantation of neuroprosthesis (LION) with neuromuscular electrical stimulation (NMES) in improving walking ability and other outcomes in individuals with spinal cord injury (SCI).", "results_summary": "The study found no significant changes in walking ability (WISCI II scale) for the NMES group, while the LION group showed improvement. No significant changes were observed in secondary outcome measures for either group.", "population_specificity": "Individuals with traumatic SCI (AIS grade A), aged 18-55, neurological level Th4-L1, and time-since-injury >1 year.", "effective_dosage": "Not specified", "study_duration": "1 year", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:51:39.815695+00:00"}
{"study_id": 76649, "supplement_id": 1374, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether adding NMES to exercise therapy during the first 14 days post-stroke improves gait recovery compared to exercise therapy alone.", "results_summary": "The study found no statistically significant improvement in walking distance (6MWT) or any secondary outcomes when NMES was added to exercise therapy. The NMES group showed a non-significant 28.3m improvement in 6MWT at 90 days, but this was not clinically meaningful.", "population_specificity": "First-ever acute ischemic stroke patients (ages 40-85) with leg paresis.", "effective_dosage": "10 minutes of daily NMES.", "study_duration": "14 days post-stroke.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:51:39.917559+00:00"}
